Home› India› Ministry of Chemicals and Fertilizers› In exercise of the powers, conferred by paragraph 4, 6, 10, ...
Date: 2014-04-28 Category: Extra Ordinary State: Union Government Country: India

In exercise of the powers, conferred by paragraph 4, 6, 10, 11, 14 and 16 of the Drugs (Prices Control) Order, 2013, read with S.O. No. 1394(E) dated the 30th May, 2013 issued by the Govt of India in the Ministry of Chemicals and Fertilizers, and in supersession of the Order of the Govt. of India in the Ministry of Chemicals and Fertilizers (National Pharmaceutical Pricing Authority) S.O. Number given in specified column no. 6 and 7 mentioned in the below.

Issued by Ministry of Chemicals and Fertilizers · Department of Pharmaceuticals

Research with AI Agent Chat with Document Generate Summary Translate Helpful Share Add to Project Create Task

Executive Summary & Key Takeaways

Executive Summary: This document from the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India, fixes and revises the ceiling prices of various scheduled drug formulations, effective April 1, 2014. It outlines the responsibilities of manufacturers regarding price revision, adherence to regulations, and reporting requirements as per the Drugs Prices Control Order (DPCO) 2013. Non-compliance will result in penalties as per the Essential Commodities Act, 1955. Key Points / Main Content: Price Fixation and Revision: * Ceiling prices are fixed for 404 scheduled drug formulations as specified in the table, exclusive of local taxes, effective April 1, 2014. * Manufacturers with Maximum Retail Prices (MRP) exceeding the set ceiling prices must revise them downwards, in accordance with DPCO 2013 paragraphs 13(1) and 24. Manufacturer Responsibilities: * Local taxes can only be added if actually paid or payable to the government on the retail price. * Manufacturers must determine the ceiling price for packs of scheduled formulations based on the specified ceiling prices, as per DPCO 2013 paragraph 11. * A price list must be issued in Form V, following DPCO 2013 paragraph 24(2). * Existing manufacturers with MRPs lower than the ceiling price (plus local taxes) must maintain their existing MRP, as per DPCO 2013 paragraph 13(2). New Drug Launches: * Existing manufacturers launching a new drug (as per DPCO 2013 paragraph 2(u)) must apply for prior price approval from the NPPA in Form I, as specified in Schedule II of DPCO 2013. Reporting and Compliance: * Manufacturers must submit quarterly reports to the NPPA regarding production, import, and sale of scheduled formulations in Form III of Schedule II of DPCO 2013. * Manufacturers intending to discontinue production/import of a scheduled formulation must inform the NPPA six months in advance in Form IV of Schedule II of DPCO 2013. * Failure to comply with ceiling prices and specified conditions will result in penalties, including depositing the overcharged amount with interest under the Essential Commodities Act, 1955, and DPCO 2013. * Previous price orders for formulations with newly issued ceiling prices are withdrawn. Retail Price Fixation of Specific Formulations: * Non-ceiling retail prices are fixed for two formulations manufactured and marketed by M/s Akums Drugs & Pharmaceuticals Pvt. Ltd. and M/s Strides Arcolab Ltd. Impact Analysis: Manufacturers: * Impact: Manufacturers must comply with the revised ceiling prices and reporting requirements. * Action Required: Revise MRPs, ensure compliance with DPCO 2013, submit quarterly reports, and inform NPPA of any intended production discontinuation. National Pharmaceutical Pricing Authority (NPPA): * Impact: The NPPA is responsible for enforcing the order and ensuring compliance. * Action Required: Monitor manufacturer compliance, review reports, and take action against non-compliant entities. Consumers: * Impact: Consumers will benefit from the revised ceiling prices, ensuring affordability of essential medicines. * Action Required: Be aware of the revised prices and report any instances of overcharging.

Key Entities Referenced

Ministry of Chemicals and Fertilizers: The ministry under which the Department of Pharmaceuticals and the National Pharmaceutical Pricing Authority (NPPA) operate. Department of Pharmaceuticals: A department operating under the Ministry of Chemicals and Fertilizers. National Pharmaceutical Pricing Authority (NPPA): A government regulatory agency responsible for fixing and revising prices of pharmaceutical products in India, operating under the Ministry of Chemicals and Fertilizers. Drugs Prices Control Order, 2013: A legal order that empowers NPPA to control prices of drugs. Akums Drugs Pharmaceuticals Pvt. Ltd.: An Indian pharmaceutical company, one of the manufacturers/marketers of specified formulations mentioned in the order. Strides Arcolab Ltd.: An Indian pharmaceutical company, one of the manufacturers/marketers of specified formulations mentioned in the order. New Delhi: The city in India where the order was issued. Essential Commodities Act, 1955: An act which when read with DPCO 2013, allows for penalties for not complying with ceiling prices.
Official Source Record View Original Source →
See Full Document Text
jftLVªh laö Mhö ,yö&33004@99 REGD. NO. D. L.-33004/99 vlk/kj.k EXTRAORDINARY Hkkx II—[k.M 3—mi&[k.M (ii) PART II—Section 3—Sub-section (ii) izkf/dkj ls izdkf'kr PUBLISHED BY AUTHORITY la. 952] ubZ fnYyh] lkseokj] vizSy 28] 2014@oS'kk[k 8] 1936 No. 952] NEW DELHI, MONDAY, APRIL 28, 2014/VAISAKHA 8, 1936 jlk;u vkSj moZjd ea=kky; ¼vkS"k/k foHkkx½ ¼jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k½ vkns'k ubZ fnYyh] 28 vizSy] 2014 dk-vk- 1156¼v½-—jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] Hkkjr ljdkj ds jlk;u vkSj moZjd ea=kky; }kjk tkjh dk0 vk0 1394¼v½ rkjh[k 30 ebZ] 2013 ds lkFk ifBr vkS"k/k ¼dher fu;a=k.k½ vkns'k] 2013 ds iSjk 4, 6, 10, 11, 14 vkSj 16 }kjk iznRr 'kfDr;ksa dk iz;ksx djrs gq,] rFkk Hkkjr ljdkj ds jlk;u vkSj moZjd ea=kky;] jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] ds vkns'k dk- vk- la[;k fofufnZ"V uhps LraHk ¼6½ vkSj ¼7½ dks vf/kØe.k djrs gq,] uhps dh lkj.kh ds LraHk ¼5½ esa fofufnZ"V vf/kdre dher dks mDr lkj.kh ds LraHk ¼3½ vkSj ¼4½ esa dh Øe'k% rRLFkkuh izfof"V;ksa esa fofufnZ"V izcyrk vkSj bZdkbZ ¼;wfuV½ lfgr ml lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa fofufnZ"V vuqlwfpr fofufeZfr;ksa esa ls izR;sd dh] LFkkuh; dj] ;fn dksbZ gS] dks NksM+dj vf/kdre dher ds #i esa fu;r djrh gSA lkj.kh Ø- vuqlwfpr fofufeZfr dk uke izcyrk bZdkbZ vf/kdre dk- vk- fnukad la- dher la[;k ¼#-½ 1 2 3 4 5 6 7 1 25% MsDlVªkst+ bUtSD'ku 100 fefy 1 fefy 0.17 2068(v) 05.07.2013 2 5- ¶Y;ksjksjsfly bUtSD'ku 250 fexzk-/ 5 1 fefy 2.21 3556(v) 02.12.2013 fefy 1780 GI/2014 (1)2 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 3 5-,feuks lsfyflfyd ,sflM 400 fexzk- 1 xksyh 9.14 1005(v) 02.04.2014 (5-,s,l,s) xksfy;k a 4 ,sflVkt+ksykekbM xksfy;ka 250 fexzk- 1 xksyh 3.92 1816(v) 21.6.2013 5 ,dk;Dyksfoj xksfy;ka 200 fexzk- 1 xksyh 7.76 1590(v) 14.6.2013 6 ,dk;Dyksfoj xksfy;ka 400 fexzk- 1 xksyh 12.38 1887(v) 28.06.2013 7 ,dk;Dyksfoj bUtsD'ku 250 fexzk-/ iSd izfr iSd 489.13 2056(v) 05.07.2013 8 ,dk;Dyksfoj bUtsD'ku 500 fexzk-/ iSd izfr iSd 461.23 3331(v) 05.11.2013 9 ,dk;Dyksfoj lLisU'ku 400 fexzk-/ 5 1 fefy 1.40 2839(v) 20.09.2013 fefy 10 ,dk;Dyksfoj Øhe 5% 1 xzke 9.44 1812(v) 21.6.2013 11 ,Ms kus kfslu bUtsD'ku 3 fexzk-/ fefy 1 fefy 121.79 1627(v) 14.6.2013 12 ,Mjsukykbu ck;VjVªsV 1 fexzk-/ fefy 1 fefy 39.59 1565(v) 14.6.2013 bUtsD'ku 13 ,ycsUMkt+ksy xksfy;ka 400 fexzk- 1 xksyh 9.70 1793(v) 21.6.2013 14 ,ycsUMkt+ksy lLisU'ku 200 fexzk-/ 5 1 fefy 1.57 1794(v) 21.6.2013 fefy 15 ,yC;wfeu bUtsD'ku 20% 1 fefy 38.98 1807(v) 21.6.2013 16 ,yksI;wjhuksy xksfy;ka 100 fexzk- 1 xksyh 2.22 2830(v) 20.09.2013 17 ,YQk bUVjQsjksu bUtsD'ku 3 fefy;u izfr iSd 807.71 1604(v) 14.6.2013 vkbZ;w 18 ,Yizkt+ksye xksfy;k a 0.25 fexzk- 1 xksyh 1.02 1817(v) 21.6.2013 19 ,Yizkt+ksye xksfy;k a 0.5 fexzk- 1 xksyh 2.14 1908(v) 28.06.2013 20 ,fedkflu bUtsD'ku 250 fexzk- / 2 1 fefy 14.84 1801(v) 21.6.2013 fefy 21 ,fe;ksMsjksu xksfy;ka 100 fexzk- 1 xksyh 6.93 1628(v) 14.6.2013 22 ,fe;ksMsjksu xksfy;ka 200 fexzk- 1 xksyh 12.41 1629(v) 14.6.2013 23 ,fe;ksMsjksu bUtsD'ku 50 fexzk-/ fefy 1 fefy 22.07 1630(v) 14.6.2013 24 ,fefVªIVk;fyu xksfy;ka 25 fexzk- 1 xksyh 2.25 1686(v) 14.6.2013 25 ,EyksfMfiu xksfy;k a 2.5 fexzk- 1 xksyh 1.90 3772(v) 20.12.2013 26 ,EyksfMfiu xksfy;k a 5 fexzk- 1 xksyh 3.01 3773(v) 20.12.2013 27 ,eksDlhflfyu ikmMj vkSj 125 fexzk- / 5 1 fefy 0.61 1795(v) 21.6.2013 lLisU'ku fefy 28 ,eksDlhflfyu dSilwy 250 fexzk- 1 dSilwy 2.93 2046(v) 05.07.2013 29 ,eksDlhflfyu dSilwy 500 fexzk- 1 dSilwy 6.47 1796(v) 21.6.2013 30 ,eksDlhflfyu+DysO;wfyfud 625 fexzk- 1 xksyh 23.88 1881(v) 28.06.2013 ,sflM xksfy;ka 31 ,eksDlhflfyu+DysO;wfyfud 228.5 fexzk-/5 1 gm 1.99 1882(v) 28.06.2013 ,sflM lLisU'ku ds fy, fefy ikmMj¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 3 32 ,eksDlhflfyu+DysO;wfyfud 600 fexzk-/ izfr iSd 91.39 1883(v) 28.06.2013 ,sflM bUtsD'ku ok;y iSd 33 ,eksDlhflfyu+DysO;wfyfud 1.2 xzke/ izfr iSd 135.42 1884(v) 28.06.2013 ,sflM bUtsD'ku ok;y iSd 34 ,EQksVsjsflu ch bUtsD'ku 50 fexzk-/ izfr iSd 4513.62 1912(v) 28.06.2013 ok;y iSd 35 ,Eihlhfyu dSilwy 250 fexzk- 1 dSilwy 2.66 2047(v) 05.07.2013 36 ,Eihlhfyu dSilwy 500 fexzk- 1 dSilwy 5.05 1797(v) 21.6.2013 37 ,Eihlhfyu lLisU'ku ds fy, 125 fexzk- / 5 1 fefy 0.67 1575(v) 14.6.2013 ikmMj fefy 38 ,Eihlhfyu bUtsD'ku 500 fexzk- izfr iSd 14.25 1798(v) 21.6.2013 39 ,aVh&Mh bE;ksuksXyksfcu ¼áweu½ 300 ,elhth izfr iSd 2349.46 1670(v) 14.6.2013 btsD'ku 40 ,aVhVsVUl áweu 250 vkbZ;w/ izfr iSd 884.75 3371(v) 05.11.2013 bE;ksuksXyksfcu bUtsD'ku iSd 41 ,aVhVsVUl áweu 500 vkbZ;w/ izfr iSd 1474.90 3372(v) 05.11.2013 bE;ksuksXyksfcu bUtsD'ku iSd 42 vkjVhL;wusV xksfy;ka ¼dsoy 50 fexzk- 1 xksyh 21.31 1802(v) 21.6.2013 lYQkMksDlhu$ik;fjfeFkkekbu dEchus'ku ds lkFk iz;ksx esa½ 43 ,Vsuksyksy xksfy;ka 50 fexzk- 1 xksyh 2.20 1810(v) 21.6.2013 44 ,Vsuksyksy xksfy;ka 100 fexzk- 1 xksyh 3.96 1632(v) 14.6.2013 45 ,VksjokLVsfVu xksfy;ka 5 fexzk- 1 xksyh 4.06 1647(v) 14.6.2013 46 ,VksjokLVsfVu xksfy;ka 10 fexzk- 1 xksyh 6.28 1811(v) 21.6.2013 47 ,VªkD;wfj;e ck;lk;ysV 10 fexzk- / izfr iSd 48.14 1674(v) 14.6.2013 bUtsD'ku fefy 48 ,Vªksikbu lYQsV bUtsD'ku 0.6 fexzk- / 1 fefy 4.26 1548(v) 14.6.2013 fefy 49 ,Vªksikbu lYQsV Mªksi 1% 1 fefy 3.09 1830(v) 21.6.2013 50 ,Vªksikbu lYQsV vkW;UVesUV 1% 1 xzke 3.44 1831(v) 21.6.2013 51 ,st+kfFk;ksfizu xksfy;ka 50 fexzk- 1 xksyh 10.52 1560(v) 14.6.2013 52 ,ftFkzksekbflu xksfy;ka 100 fexzk- 1 xksyh 5.45 2051(v) 05.07.2013 53 ,ftFkzksekbflu xksfy;ka 250 fexzk- 1 xksyh 10.91 2052(v) 05.07.2013 54 ,ftFkzksekbflu xksfy;ka 500 fexzk- 1 xksyh 21.81 3379(v) 05.11.2013 55 ,ftFkzksekbflu lLisU'ku 100 fexzk-/5 1 fefy 1.65 2237(v) 22.07.2013 fefy 56 ,ftFkzksekbflu bUtsD'ku 500 fexzk- izfr iSd 193.79 1578(v) 14.6.2013 57 fcdyksfeFkkt+ksu MkbZizksfi;ksusV 50 ,elhth/ 1 bUgsyj 180.07 2846(v) 20.09.2013 bUgsys'ku Mkst+4 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 58 fcdyksfeFkkt+ksu MkbZizksfi;ksusV 250 ,elhth / izfr ehVj 1.62 1690(v) 14.6.2013 bUgsys'ku ehVj Mkst+ Mkst+ 59 csUtksbu dEikmaM fVadpj 1 fefy 0.34 3561(v) 02.12.2013 60 csUtk;y csUtq,sV yks'ku 25% 1 fefy 0.15 3560(v) 02.12.2013 61 csVkDlksyksy gkbMªksDyksjkbM 0.25% 1 fefy 4.24 3374(v) 05.11.2013 Mªksi 62 csVkDlksyksy gkbMªksDyksjkbM 0.50% 1 fefy 7.01 1677(v) 14.6.2013 Mªksi 63 fclkdksfMy xksfy;ka 5 fexzk- 1 xksyh 1.03 2065(v) 05.07.2013 64 fclkdksfMy likfslVjh a 5 fexzk- 1 LiksflVjh 8.47 3369(v) 05.11.2013 65 fcY;kskekbflu bUtsD'ku 15 fexzk- 1 ml 654.99 1605(v) 14.6.2013 66 czkseksfØIVkbu eslk;ysV 1.25 fexzk- 1 xksyh 8.06 1805(v) 21.6.2013 xksfy;ka 67 czkseksfØIVkbu eslk;ysV 2.5 fexzk- 1 xksyh 14.46 1806(v) 21.6.2013 xksfy;ka 68 C;wihosdsu gkbMªksDyksjkbV 0.25% 1 fefy 2.46 2851(v) 20.09.2013 bUtsD'ku 69 C;wihosdsu gkbMªksDyksjkbV 0.5% 1 fefy 3.71 2852(v) 20.09.2013 bUtsD'ku 70 C;wihosdsu gkbMªksDyksjkbV 0.5% feDlM 1 fefy 6.09 2853(v) 20.09.2013 bUtsD'ku lfgr 7.5% Xydw ksl lkYs ;”w ku 71 cwlwyQsu xksfy;ka 2 fexzk- 1 xksyh 3.63 3363(v) 05.11.2013 72 Dsykekbu yks'ku 1 fefy/ 1.03 2859(v) 20.09.2013 xzke 73 dSfY'k;e dkcksZusV xksfy;ka 250 fexzk- 1 xksyh 1.79 2867(v) 20.09.2013 74 dSfY'k;e dkcksZusV xksfy;ka 500 fexzk- 1 xksyh 1.78 2255(v) 22.07.2013 75 dSfY'k;e XywdksusV bUtsD'ku 100 fexzk-/ 10 fefy 10.58 2868(v) 20.09.2013 fefy esa 10 ,Ei;wy fefy ,Ei;wy 76 dkfcZekt+ksy xksfy;ka 5 fexzk- 1 xksyh 1.88 1668(v) 14.6.2013 77 dkfcZekt+ksy xksfy;ka 10 fexzk- 1 xksyh 3.65 1669(v) 14.6.2013 78 dkcksZIysfVu bUtsd'ku 150 fexzk- / izfr iSd 838.88 1895(v) 28.06.2013 ok;y iSd 79 dkcksZIysfVu bUtsd'ku 450 fexzk-/ izfr iSd 2578.19 1916(v) 28.06.2013 ok;y 80 lsfQfDle xksfy;ka 100 fexzk- 1 xksyh 8.18 1820(v) 21.6.2013 81 lsfQfDle xksfy;ka 200 fexzk- 1 xksyh 11.96 2236(v) 22.07.2013¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 5 82 lsQVkftfMe bUtsD'ku 250 fexzk- izfr iSd 67.41 1576(v) 14.6.2013 83 lsQVkftfMe bUtsD'ku 1 xzke izfr iSd 243.67 1799(v) 21.6.2013 84 lsQfVª;kDlksu bUtsD'ku 250 fexzk- izfr iSd 26.15 1800(v) 21.6.2013 85 lsQfVª;kDlksu bUtsD'ku 1 xzke izfr iSd 58.94 2235(v) 22.07.2013 86 lsQsysfDlu flji 125 fexzk- / 5 1 fefy 0.97 2050(v) 05.07.2013 fefy 87 lsQsysfDlu dSilwy 250 fexzk- 1 dSilwy 5.58 2048(v) 05.07.2013 88 lsQsysfDlu dSilwy 500 fexzk- 1 dSilwy 12.39 2049(v) 05.07.2013 89 flfVªekbM lksY;w'ku 20% 1 fefy 0.46 2249(v) 22.07.2013 (Mk;Y;”w ku d s fy, dUd-) 90 flfVªt+u xksfy;ka 10 fexzk- 1 xksyh 1.92 1875(v) 28.06.2013 91 flfVªt+u flji 5 fexzk-/ fefy 1 fefy 0.57 1876(v) 28.06.2013 92 DyksjkeC;wfly xksfy;ka 2 fexzk- 1 xksyh 48.08 3342(v) 05.11.2013 93 DyksjkeQsfudksy Mªksi 1% 1 fefy 4.53 3353(v) 05.11.2013 94 DyksjkeQsfudksy vkW;UVesUV 1% 1 xzke 4.53 2070(v) 05.07.2013 95 DyksjksQsfujkekbu esfy,sV 4 fexzk- 1 xksyh 0.11 2232(v) 22.07.2013 xksfy;ka 96 lhlIysfVu bUtsD'ku 10 fexzk- izfr iSd 90.20 2241(v) 22.07.2013 97 lhlIysfVu bUtsD'ku 50 fexzk- / izfr iSd 320.30 1890(v) 28.06.2013 ok;y iSd 98 fdfyUMkekbflu xksfy;ka 300 fexzk- 1 xksyh 13.92 3332(v) 05.11.2013 99 DyksQkft+feu dSilwy 50 fexzk- 1 dSilwy 1.36 1581(v) 14.6.2013 100 DyksQkft+feu dSilwy 100 fexzk- 1 dSilwy 2.36 1582(v) 14.6.2013 101 DyksfeQsu lkbVªsV xksfy;ka 50 fexzk- 1 xksyh 8.43 1906(v) 28.06.2013 102 DyksfeQsu lkbVªsV xksfy;ka 100 fexzk- 1 xksyh 12.95 1664(v) 14.6.2013 103 DyksfiMksxjsy xksfy;ka 75 fexzk- 1 xksyh 10.66 2060(v) 05.07.2013 104 DyksfVªekt+ksy islkfjt+ 100 fexzk- 1 islfjt+ 9.24 423(v) 17.02.2014 105 DyksfVªekt+ksy islkfjt+ 200 fexzk- 1 islfjt+ 14.15 922(v) 27.03.2014 106 DyksfVªekt+ksy islkfjt+ tWy 2% 1 xzke 2.20 1886(v) 28.06.2013 107 dksYphflu xksfy;ka 0.5 fexzk- 1 xksyh 3.06 1559(v) 14.6.2013 108 dkWuMkWe 1 dkWUMe 6.97 3348(v) 05.11.2013 109 lkbDyksQksLQkekbM xksfy;ka 50 fexzk- 1 xksyh 3.99 1606(v) 14.6.2013 110 lkbDyksQksLQkekbM bUtsD'ku 500 fexzk- 1 77.31 2529(v) 21.08.2013 bUtsDVscy 111 lkbDyksliksjkbu dSilwy 25 fexzk- 1 dSilwy 26.31 1602(v) 14.6.2013 112 lkbDyksliksjkbu dSilwy 50 fexzk- 1 dSilwy 51.31 1603(v) 14.6.20136 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 113 lkbDyksliksjkbu dSilwy 100 fexzk- 1 dSilwy 113.01 1889(v) 28.06.2013 114 lkbDyksliksjkbu dUlUVªsV ds 100 fexzk-/ 1 fefy 126.14 3333(v) 05.11.2013 fy, bUtsD'ku fefy 115 lkbVksflu ,sjkfcukslkbM 100 fexzk-/ izfr iSd 253.51 1914(v) 28.06.2013 bUtsD'ku ok;y 116 lkbVksflu ,sjkfcukslkbM 500 fexzk-/ izfr iSd 548.11 1891(v) 28.06.2013 bUtsD'ku ok;y 117 lkbVksflu ,sjkfcukslkbM 1000 fexzk-/ izfr iSd 1244.60 1892(v) 28.06.2013 bUtsD'ku ok;y 118 Mh-ih-Vh- osfDlu bUtsD'ku 1 ok;y 247.58 1671(v) 14.6.2013 119 MsdkckZft+u bUtsd'ku 500 fexzk- izfr iSd 1094.13 1614(v) 14.6.2013 120 Msukt+ksy dSilwy 50 fexzk- 1 dSilwy 9.96 1607(v) 14.6.2013 121 Msukt+ksy dSilwy 100 fexzk- 1 dSilwy 21.61 1608(v) 14.6.2013 122 Msilksu xksfy;ka 50 fexzk- 1 xksyh 0.21 2835(v) 20.09.2013 123 Msilksu xksfy;ka 100 fexzk- 1 xksyh 0.23 2836(v) 20.09.2013 124 Ms;uksjchflu bUtsD'ku 20 fexzk- izfr iSd 376.04 3341(v) 05.11.2013 /ok;y iSd 125 MslQsfj;ksDlkekbu eslk;ysV 500 fexzk- izfr iSd 158.03 3355(v) 05.11.2013 bUtsD'ku 126 MsDlDyksjksQsfujkekbu esfy,sV 0.5 fexzk- / 5 1 fefy 0.32 2831(v) 20.09.2013 flji fefy 127 MsDlVªku -40 bUtsD'ku 10% 1 fefy 0.80 3344(v) 05.11.2013 128 fM;kt+kike bUtsD'ku 5 fexzk-/ fefy 1 fefy 5.94 1549(v) 14.6.2013 129 fM;kt+kike xksfy;ka 2 fexzk- 1 xksyh 1.53 2533(v) 21.08.2013 130 fM;kt+kike xksfy;k 5 fexzk- 1 xksyh 1.40 1832(v) 21.6.2013 131 fMDyksQsusd xksfy;ka 50 fexzk- 1 xksyh 2.07 1909(v) 28.06.2013 132 fMDyksQsusd bUtsD'ku 25 fexzk- / fefy 1 fefy 1.58 2869(v) 20.09.2013 133 MkbZlkbDyksekbu 10 fexzk- / fefy 1 fefy 3.14 2064(v) 05.07.2013 gkbMªksDyksjkbM bUtsD'ku 134 fMMkuksflu xksfy;ka 250 fexzk- 1 xksyh 25.44 2840(v) 20.09.2013 135 MkbZbFkk;ydkckZt+kbu lkbVªsV 50 fexzk- 1 xksyh 0.50 1574(v) 14.6.2013 xksfy;ka 136 fMxksDlhu xksfy;ka 0.25 fexzk- 1 xksyh 1.34 1641(v) 14.6.2013 137 fMxksDlhu bUtsD'ku 0.25 fexzk-/ 1 fefy 3.98 422(v) 17.02.2014 fefy 138 MkbZgkbMªks,sjxksVkekbu xksfy;ka 1 fexzk- 1 xksyh 17.77 1601(v) 14.6.2013 139 MkbZyksDlkukbM ¶;wjsV xksfy;ka 500 fexzk- 1 xksyh 1.71 3361(v) 05.11.2013¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 7 140 fMfYV;kt+se xksfy;ka 30 fexzk- 1 xksyh 2.41 1622(v) 14.6.2013 141 fMfYV;kt+se xksfy;ka 60 fexzk- 1 xksyh 5.09 1899(v) 28.06.2013 142 fMfYV;kt+se bUtsD'ku 5 fexzk-/ fefy 1 fefy 3.21 2843(v) 20.09.2013 143 Mk;IFksfj;k ,aVhVksDlhu 10,000 izfr iSd 1229.06 3349(v) 05.11.2013 bUtsD'ku vkbZ;w@iSd 144 MksC;wVkfeu bUtsD'ku 50 fexzk- / fefy izfr iSd 69.55 1642(v) 14.6.2013 145 MkseisfjMksu xksfy;ka 10 fexzk- 1 xksyh 2.40 2063(v) 05.07.2013 146 MkseisfjMksu flji 1 fexzk- / fefy 1 fefy 1.10 1654(v) 14.6.2013 147 Mksikekbu gkbMªksDyksjkbM 40 fexzk- / fefy 1 fefy 5.88 1643(v) 14.6.2013 21.8.2013 bUtsD'ku 2536(v) 148 MksDlks:fclhu bUtsD'ku 10 fexzk- / izfr iSd 208.90 1893(v) 28.06.2013 ok;y iSd 149 MksDlks:fclhu bUtsD'ku 50 mg izfr iSd 1217.58 1609(v) 14.6.2013 150 ,sQkfojsUt+ dSilwy 200 fexzk- 1 dSilwy 24.62 3359(v) 05.11.2013 151 bZ,e,y, Øhe 1 xzke 21.35 1547(v) 14.6.2013 152 ,ukykfizy esfy,sV xksfy;ka 2.5 fexzk- 1 xksyh 1.89 1633(v) 14.6.2013 153 ,ukykfizy esfy,sV xksfy;ka 5 fexzk- 1 xksyh 3.15 1634(v) 14.6.2013 154 ,uksDlkisfju bUtsD'ku 40 fexzk- izfr iSd 467.16 2246(v) 22.07.2013 155 ,uksDlkisfju bUtsD'ku 60 fexzk-/ iSd izfr iSd 564.54 1917(v) 28.06.2013 156 ,Leksyksy bUtsD'ku 10 fexzk- / fefy 1 fefy 21.81 1631(v) 14.6.2013 157 bFkkeC;wVksy xksfy;ka 200 fexzk- 1 xksyh 1.03 2837(v) 20.09.2013 158 bFkkeC;wVksy xksfy;ka 400 fexzk- 1 xksyh 2.31 1583(v) 14.6.2013 159 bFkkeC;wVksy xksfy;ka 600 fexzk- 1 xksyh 3.35 1584(v) 14.6.2013 160 bFkkeC;wVksy xksfy;ka 800 fexzk- 1 xksyh 3.98 1585(v) 14.6.2013 161 ,fFkuk;y,LVªsfM;ksy xksfy;ka 0.01 fexzk- 1 xksyh 2.25 1660(v) 14.6.2013 162 ,fFkuk;y,LVªsfM;ksy xksfy;ka 0.05 fexzk- 1 xksyh 3.75 3370(v) 05.11.2013 163 ,fFkuk;y,LVªsfM;ksy 0.03 fexzk- 1 xksyh 3.24 2067(v) 05.07.2013 $ysoksuksjxsLVªksy xksfy;ka +0.15 fexzk- 164 bFkk;y ,YdksgWy 70% - 1 fefy 0.52 3766(v) 20.12.2013 lksY;w'ku 165 ,VksikslkbM dSilwy 100 fexzk- 1 dSilwy 55.61 3364(v) 05.11.2013 166 ,VksikslkbM bUtsD'ku 100 fexzk-/ 5 izfr iSd 204.55 1915(v) 28.06.2013 fefy ok;y 167 QsDVj VIII dUlsUVªsV bUtsD'ku MªkbM izfr iSd 6464.71 3345(v) 05.11.2013 168 QsUVkuk;y bUtsD'ku 50 ,elhth/ 1 fefy 21.54 1558(v) 14.6.20138 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] fefy 169 fQyxzkLVhe bUtsD'ku 1 fefy 2278.21 1897(v) 28.06.2013 170 ¶Y;wdksukt+ksy dSilwy 50 fexzk- 1 dSilwy 10.80 1822(v) 21.6.2013 171 ¶Y;wdksukt+ksy xksfy;ka 50 fexzk- 1 xksyh 8.32 1823(v) 21.6.2013 172 ¶Y;wdksukt+ksy dSilwy 100 fexzk- 1 dSilwy 25.31 2849(v) 20.09.2013 173 ¶Y;wdksukt+ksy xksfy;ka 100 fexzk- 1 xksyh 15.05 1824(v) 21.6.2013 174 ¶Y;wdksukt+ksy dSilwy 150 fexzk- 1 dSilwy 25.08 2054(v) 05.07.2013 175 ¶Y;wdksukt+ksy xksfy;ka 150 fexzk- 1 xksyh 15.36 2055(v) 05.07.2013 176 ¶Y;wdksukt+ksy dSilwy 200 fexzk- 1 dSilwy 41.37 1825(v) 21.6.2013 177 ¶Y;wdksukt+ksy xksfy;ka 200 fexzk- 1 xksyh 27.49 1826(v) 21.6.2013 178 ¶Y;w,sfDlVu gkbMªksDyksjkbM 20 fexzk- 1 dSilwy 3.69 1922(v) 28.06.2013 dSilwy 179 ¶Y;wVkekbM xksfy;ka 250 fexzk- 1 xksyh 9.16 1894(v) 28.06.2013 180 Qksfyd ,sflM xksfy;ka 1 fexzk- 1 xksyh 0.27 3365(v) 05.11.2013 181 Qksfyd ,sflM xksfy;ka 5 fexzk- 1 xksyh 1.46 3570(v) 02.12.2013 182 tSeflVkfcu gkbMªksDyksjkbM 200 fexzk- izfr iSd 1387.33 1610(v) 14.6.2013 bUtsD'ku 183 tSeflVkfcu gkbMªksDyksjkbM 1 xzke izfr iSd 6346.41 1611(v) 14.6.2013 bUtsD'ku 184 tSfUV;ku okW;ysV iSUV 1% 1 fefy 0.06 3767(v) 20.12.2013 185 fxfycsUdykekbM xksfy;ka 2.5 fexzk- 1 xksyh 0.51 1661(v) 14.6.2013 186 fxfycsUdykekbM xksfy;ka 5 fexzk- 1 xksyh 1.02 1662(v) 14.6.2013 187 Xywdkxksu bUtsD'ku 1 fexzk-/ fefy izfr iSd 838.15 1663(v) 14.6.2013 188 Xywdksl bUtsD'ku 10% 1 fefy 0.05 1819(v) 21.6.2013 189 XywVjkyfMgkbM lksY;w'ku 2% 1 fefy 0.09 2860(v) 20.09.2013 190 Xyk;lfju lksY;w'ku 1 fefy 0.31 3559(v) 02.12.2013 191 Xyk;lfjy VªkbZukbVªsV 0.5 fexzk- 1 xksyh 1.97 1623(v) 14.6.2013 lcfyaxoy xksfy;ka 192 Xyk;lfjy VªkbZukbVªsV 5 fexzk-/ fefy 1 fefy 8.01 1624(v) 14.6.2013 lcfyaxoy bUtsD'ku 193 gsyksisfjMksy bUtsD'ku 5 fexzk-/ fefy 1 fefy 5.99 1683(v) 14.6.2013 194 gsyksFksu osiksjkbt+j lfgr 1 fefy 6.24 1542(v) 14.6.2013 bUgsys'ku 195 gsikfju lksfM;e bUtsD'ku 5000 1 fefy 43.19 2858(v) 20.09.2013 vkbZ;w/fefy 196 gsikfju lksfM;e bUtsD'ku 1000 1 fefy 18.61 3764(v) 20.12.2013 vkbZ;w/fefy¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 9 197 gsikVsfVl ch osfDlu bUtsD'ku 1 fefy 107.48 3351(v) 05.11.2013 198 gksekVªksikbu Mªksi 2% 1 fefy 5.78 3573(v) 02.12.2013 199 gkbMªksDyksjfFk;kft+M xksfy;ka 12.5 fexzk- 1 xksyh 1.03 1639(v) 14.6.2013 200 gkbMªksDyksjfFk;kft+M xksfy;ka 25 fexzk- 1 xksyh 1.76 1640(v) 14.6.2013 201 gkbMªksdksfVZlksu lksfM;e 100 fexzk- izfr iSd 39.48 2233(v) 22.07.2013 lDlhusV bUtsD'ku 202 gkbMªksdksfVZlksu lksfM;e 200 fexzk- 1 fefy 75.97 2847(v) 20.09.2013 lDlhusV bUtsD'ku 203 gkbMªksdksfVZlksu lksfM;e 400 fexzk- izfr iSd 144.28 1691(v) 14.6.2013 lDlhusV bUtsD'ku 204 gkbMªkst+u isjksDlkbM lksY;w'ku 6% 1 fefy 0.05 3768(v) 20.12.2013 205 gkbMªksDlhDyksjkDohu 200 fexzk- 1 xksyh 6.00 1563(v) 14.6.2013 QksLQsV@lYQsV xksfy;ka 206 gkbMªksDlhbFkk;y LVkpZ 6% 1 fefy 0.79 3366(v) 05.11.2013 ¼gsVkLVkpZ½ bUtsD'ku 207 gk;kslkbu C;wVkby czksekbM 10 fexzk- 1 xksyh 3.01 3347(v) 05.11.2013 xksfy;ka 208 gk;kslkbu C;wVkby czksekbM 20 fexzk- / fefy 1 fefy 10.46 1658(v) 14.6.2013 bUtsD'ku 209 vkbQkslQkekbM bUtsD'ku 1 xzke / 2 fefy izfr iSd 366.68 3558(v) 02.12.2013 17.02.2014 ok;y 430(v) 210 bekfVfuc xkfsy;k a 100 fexzk- 1 xksyh 93.13 1827(v) 21.06.2013 211 bekfVfuc xkfsy;k a 400 fexzk- 1 xksyh 285.29 1615(v) 14.6.2013 212 behizkekbu xksfy;ka 25 fexzk- 1 xksyh 0.80 1687(v) 14.6.2013 213 behizkekbu xksfy;ka 75 fexzk- 1 xksyh 2.13 1688(v) 14.6.2013 214 baMhusfoj dSilwy 400 fexzk- 1 dSilwy 20.64 1596(v) 14.6.2013 215 vkbizkVªksfi;e czksekbM 20 ,elhth / 1 ehVj 0.72 2848(v) 20.09.2013 bUgsys'ku ehVj Mkst + Mkst 216 vk;ju MsDlVªksu bUtsD'ku 50 fexzk- 1 fefy 30.52 2245(v) 22.07.2013 vk;ju/ fefy 217 vkblks¶Y;wjsu bUgsys'ku 1 fefy 11.41 2230(v) 22.07.2013 218 vkblksfu;kft+M xksfy;ka 100 fexzk- 1 xksyh 0.77 2838(v) 20.09.2013 219 vkblksfu;kft+M xksfy;ka 300 fexzk- 1 xksyh 1.35 2238(v) 22.07.2013 220 vkblksfu;kft+M flji 100 fexzk-/5 1 fefy 0.23 3357(v) 05.11.2013 fefy 221 vkbZlkslksjfcM 5 eksuksukbVªsV 10 fexzk- 1 xksyh 2.04 1625(v) 14.6.2013 xksfy;ka10 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 222 vkbZlkslksjfcM 5 eksuksukbVªsV 20 fexzk- 1 xksyh 3.50 1626(v) 14.6.2013 xksfy;ka 223 vkbZlkslksjfcM MkbZukbVªsV 10 fexzk- 1 xksyh 0.73 2057(v) 05.07.2013 xksfy;ka 224 bLikxwyk xzsU;wYl 1 xzke 0.81 1813(v) 21.6.2013 225 fdVkekbu gkbMªksdyksjkbM 50 fexzk- / fefy 1 fefy 11.12 1543(v) 14.6.2013 bUtsD'ku 226 ,y&,likjkfxust+ bUtsD'ku 5000 ds;w@iSd izfr iSd 1258.74 3334(v) 05.11.2013 227 ysfe;wMkbuu xksfy;ka 150 fexzk- 1 xksyh 9.99 1888(v) 28.06.2013 228 ysfe;wMkbu$usfojsikbu$ 150 fexzk- + 1 xksyh 18.38 1591(v) 14.6.2013 LVsO;wMkbu xksfy;ka 200 fexzk-+ 30 fexzk- 229 ysfe;wMkbu$ ft+MksO;wMkbu 150 fexzk- + 1 xksyh 20.87 1592(v) 14.6.2013 xksfy;ka 300 fexzk- 230 ysQY;wuksekbM xksfy;ka 10 fexzk- 1 xksyh 16.05 1874(v) 28.06.2013 231 ysQY;wuksekbM xksfy;ka 20 fexzk- 1 xksyh 30.44 1564(v) 14.6.2013 232 ysoksFkk;jksfDlu xksfy;ka 50 ,elhth 1 xksyh 1.07 2069(v) 05.07.2013 233 ysoksFkk;jksfDlu xksfy;ka 100 ,elhth 1 xksyh 1.18 1815(v) 21.6.2013 234 fyXuksdsu gkbMªksDyksjkbM 2-5% 1 fefy / 1.25 2854(v) 20.09.2013 VkWfidy QkseZl xzke 235a fyXuksdsu gkbMªksDyksjkbM 1% izfr iSd 7.30 3376(v) 05.11.2013 bUtsD'ku 235b fyXuksdsu gkbMªksDyksjkbM 2% 1 fefy 1.06 2248(v) 22.07.2013 bUtsD'ku 236 fyXuksdsu gkbMªksDyksjkbM$ 1%+ izfr iSd 0.72 1546(v) 14.6.2013 ,Mjsukykbu bUtsD'ku 1:200,000/iSd 237 fyXuksdsu gkbMªksDyksjkbM$ 2% + 1 fefy 0.98 923(v) 27.03.2014 ,Mjsukykbu bUtsD'ku 1:200,000/iSd 238 fyfFk;e dkcksZusV xksfy;ka 300 fexzk- 1 xksyh 1.50 1689(v) 14.6.2013 239 yksjkt+sike bUtsD'ku 2 fexzk-/ fefy 1 fefy 7.86 1573(v) 14.6.2013 240 ykslkjVsu iksVkf'k;e xksfy;ka 25 fexzk- 1 xksyh 2.66 1635(v) 14.6.2013 241 ykslkjVsu iksVkf'k;e xksfy;ka 50 fexzk- 1 xksyh 4.57 1636(v) 14.6.2013 242 eSxusf'k;e lYQsV bUtsD'ku 500 fexzk- / 1 fefy 5.27 3328(v) 05.11.2013 fefy 243 esfuuVksy bUtsD'ku 10% 1 fefy 0.24 3572(v) 02.12.2013 244 esfuuVksy bUtsD'ku 20% 1 fefy 0.37 2062(v) 05.07.2013¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 11 245 Ekhlysl osfDlu bUtsD'ku izfr iSd 268.96 3352(v) 05.11.2013 246 esMªksDlhu izksxsLVªksu ,sflVsV 5 fexzk- 1 xksyh 2.75 1665(v) 14.6.2013 xksfy;ka 247 esMªksDlhu izksxsLVªksu ,sflVsV 10 fexzk- 1 xksyh 5.57 1666(v) 14.6.2013 xksfy;ka 248 es¶yksDohu xksfy;ka 250 fexzk- csl 1 xksyh 53.22 1600(v) 14.6.2013 249 esYQkysu xksfy;ka 2 fexzk- 1 xksyh 115.39 3335(v) 05.11.2013 250 esYQkysu xksfy;ka 5 fexzk- 1 xksyh 193.57 3336(v) 05.11.2013 251 esjdsIVksI;wfju xksfy;ka 50 fexzk- 1 xksyh 9.49 3337(v) 05.11.2013 252 esLuk bUtsD'ku 200 fexzk- 1 fefy 26.12 2243(v) 22.07.2013 253 esVQksjfeu xksfy;ka 500 fexzk- 1 xksyh 1.66 1814(v) 21.6.2013 254 esFkksVªsDlsV xksfy;ka 5 fexzk- 1 xksyh 8.08 1561(v) 14.6.2013 255 esFkksVªsDlsV xksfy;ka 7.5 fexzk- 1 xksyh 11.98 1562(v) 14.6.2013 256 esFkksVªsDlsV xksfy;ka 10 fexzk- 1 xksyh 14.83 1873(v) 28.06.2013 257 esFkksVªsDlsV xksfy;ka 2.5 mg 1 xksyh 5.02 1612(v) 14.6.2013 258 esFkksVªsDlsV bUtsD'ku 50 fexzk- / 1 fefy 35.28 2242(v) 22.07.2013 fefy 259 feFkk;y ,jxksesVjkbu xksfy;k 0.125 fexzk- 1 xksyh 7.59 1679(v) 14.6.2013 260 feFkk;y ,jxksesVjkbu 0.2 fexzk-/ 1 fefy 14.26 3769(v) 20.12.2013 bUtsD'ku fefy 261 feFkk;y izsMuhlksyksu 40 fexzk-/ fefy 1 fefy 66.49 2066(v) 05.07.2013 bUtsD'ku 262 esVksDyksizkekbM xksfy;ka 10 fexzk- 1 xksyh 1.11 1655(v) 14.6.2013 263 esVksDyksizkekbM flji 5 fexzk- /5 1 ml 0.50 1656(v) 14.6.2013 fefy 264 esVksDyksizkekbM bUtsD'ku 5 fexzk- / fefy 1 fefy 2.22 1657(v) 14.6.2013 265 esVksizksyksy xksfy;ka 25 fexzk- 1 xksyh 3.59 3770(v) 20.12.2013 266 esVksizksyksy xksfy;ka 50 fexzk- 1 xksyh 5.33 3771(v) 20.12.2013 267 esVksizksyksy bUtsD'ku 1 fexzk- / fefy 1 fefy 2.77 2247(v) 22.07.2013 268 fedksukt+ksy vkW;UVesUV 2% 1 xzke 2.33 1903(v) 28.06.2013 269 fedksukt+ksy Øhe 2% 1 xzke 1.48 1904(v) 28.06.2013 270 feMkt+kYs e bUtsD'ku 1 fexzk- / fefy 1 fefy 6.16 1550(v) 14.6.2013 271 feMkt+kYs e bUtsD'ku 5 fexzk-/ fefy 1 fefy 26.35 1551(v) 14.6.2013 272 ekbQfizLVksu xksfy;ka 200 fexzk- 1 xksyh 379.70 2254(v) 22.07.2013 273 felksizksLVksy xksfy;ka 100 ,elhth 1 xksyh 10.03 1681(v) 14.6.2013 274 feVksekbflu&lh bUtsD'ku 10 fexzk- izfr iSd 422.70 3557(v) 02.12.201312 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 275 eksjQkbu lYQsV bUtsD'ku 10 fexzk-/ fefy 1 fefy 22.88 2856(v) 20.09.2013 276 eksjQkbu lYQsV xksfy;ka 10 fexzk- 1 xksyh 5.36 2857(v) 20.09.2013 277 ,u&,sflVk;ylk;LfVu 200 fexzk-/ 1 fefy 23.94 1568(v) 14.6.2013 bUtsD'ku fefy 278 usyksDlksu bUtsD'ku 0.4 fexzk-/ 1 fefy 97.29 2234(v) 22.07.2013 fefy 279 fu;ksLVht+ekbu xksfy;ka 15 fexzk- 1 xksyh 4.92 3373(v) 05.11.2013 280 fu;ksLVht+ekbu bUtsD'ku 0.5 fexzk- / 1 fefy 4.30 1675(v) 14.6.2013 21.8.2013 fefy 2537(v) 281 Uksfojsikbu lLisU'ku 50 fexzk- / 5 1 fefy 1.04 1595(v) 14.6.2013 fefy 282 ukbQfMfiu dSilwy 5 fexzk- 1 dSilwy 0.91 1900(v) 28.06.2013 283 ukbQfMfiu dSilwy 10 fexzk- 1 dSilwy 1.25 1637(v) 14.6.2013 284 ukbQfMfiu xksfy;ka 10 fexzk- 1 xksyh 1.20 1638(v) 14.6.2013 285 ukbQfMfiu lLVsUM fjfyt 10 fexzk- 1 xksyh 1.51 1901(v) 28.06.2013 xksfy;ka 286 ukbQfMfiu lLVsUM fjfyt 10 fexzk- 1 dSilwy 1.78 2844(v) 20.09.2013 dSilwy 287 ukbQfMfiu lLVsUM fjfyt 20 fexzk- 1 xksyh 2.02 2061(v) 05.07.2013 xksfy;ka 288 ukbQfMfiu lLVsUM fjfyt 20 fexzk- 1 dSilwy 2.33 2845(v) 20.09.2013 dSilwy 289 ukbQfMfiu xksfy;ka 20 mg 1 xksyh 0.34 3563(v) 02.12.2013 290 ukbVªk¶;wjsufV;ksu xksfy;ka 100 fexzk- 1 xksyh 7.31 1885(v) 28.06.2013 291 ukbVªl vkWDlkbM bUgsys'ku - D;wfcd 219.21 3762(v) 20.12.2013 ehVj 292 Ukksj,fFkfLVª;ksu xksfy;ka 5 fexzk- 1 xksyh 5.39 1667(v) 14.6.2013 293 vkW¶yksDlhu xksfy;ka 100 fexzk- 1 xksyh 3.51 2053(v) 05.07.2013 294 vkW¶yksDlhu xksfy;ka 200 fexzk- 1 xksyh 5.21 2239(v) 22.07.2013 295 vkW¶yksDlhu flji 50 fexzk-/5 1 fefy 0.71 1586(v) 14.6.2013 fefy 296 vksyut+kikbu xksfy;ka 5 fexzk- 1 xksyh 3.08 1684(v) 14.6.2013 297 vksyut+kikbu xksfy;k 10 fexzk- 1 xksyh 5.66 1685(v) 14.6.2013 298 vksesizkt+ksy dSilwy 10 fexzk- 1 dSilwy 2.93 1828(v) 21.6.2013 299 vksesizkt+ksy dSilwy 20 fexzk- 1 dSilwy 3.21 1829(v) 21.6.2013 300 vksesizkt+ksy dSilwy 40 fexzk- 1 dSilwy 6.51 3346(v) 05.11.2013 301 vkWuMsUlsVªksu xksfy;ka 4 fexzk- 1 xksyh 5.06 2244(v) 22.07.2013¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 13 302 vkWuMsUlsVªksu xksfy;k 8 fexzk- 1 xksyh 11.77 1618(v) 14.6.2013 303 vkWuMsUlsVªksu bUtsD'ku 2 fexzk- / fefy 1 fefy 7.84 1803(v) 21.6.2013 304 vkWuMsUlsVªksu flji 2 fexzk- /5 1 fefy 1.11 1804(v) 21.6.2013 fefy 305 vkWjy iksfy;kek;ysfVl 1 fefy 106.21 3774(v) 20.12.2013 osfDlu ¼,y,½ lksY;w'ku 306 vkWjy fjgk;Mªs'ku lkWYV vkb-Zih- d s 1 xzke 0.89 2531(v) 21.08.2013 lksY;w'ku ds fy, ikmMj vk/kkj ij 307 vkWDlkyhIysfVu bUtsD'ku 50 fexzk- 1 bUtsDVscy 3182.43 2530(v) 21.08.2013 ok;y 308 vkWDlht+u bUgsys'ku - D;wfcd 16.81 3763(v) 20.12.2013 ehVj 309 vkWDlhVksflu bUtsD'ku 5 vkbZ;w/ fefy 1 fefy 17.26 1921(v) 28.06.2013 310 vkWDlhVksflu bUtsD'ku 10 vkbZ;w/ 1 fefy 40.08 1680(v) 14.6.2013 fefy 311 isfDyVsDlsy bUtsD'ku 30 fexzk- / 5 izfr iSd 320.28 3338(v) 05.11.2013 fefy 312 iSUVksizkt+ksy bUtsD'ku 40 fexzk- izfr iSd 50.96 1653(v) 14.6.2013 313 iSjkflVkeksy bUtsD'ku 150 fexzk- / 1 fefy 3.65 3567(v) 02.12.2013 fefy 314 iSjkflVkeksy flji 125 fexzk- / 5 1 fefy 0.34 421(v) 17.02.2014 fefy 315 iSjkflVkeksy xksfy;ka 500 fexzk- 1 xksyh 1.00 1555(v) 14.6.2013 316 iSjkflVkeksy liksflVjh 80 fexzk- 1 LiksflVjh 7.40 3568(v) 02.12.2013 317 iSjkflVkeksy liksflVjh 170 fexzk- 1 LiksflVjh 8.58 3569(v) 02.12.2013 318 isfuflykekbu dSilwy 250 fexzk- 1 dSilwy 13.95 1567(v) 14.6.2013 319 ijesFkfju Øhe 5% 1 xzke 1.88 1648(v) 14.6.2013 320 ijesFkfju yks'ku 5% 1 fefy 1.14 1649(v) 14.6.2013 321 ijesFkfju yks'ku 1% 1 xzke 0.96 3564(v) 02.12.2013 322 QsuksckjfcVksu xksfy;ka 30 fexzk- 1 xksyh 0.99 1877(v) 28.06.2013 323 QsuksckjfcVksu xksfy;ka 60 fexzk- 1 xksyh 1.80 1569(v) 14.6.2013 324 QsuksckjfcVksu bUtsD'ku 200 fexzk-/ 1 fefy 19.94 2526(v) 21.08.2013 fefy 325 QsuksckjfcVksu flji 20 fexzk-/5 1 fefy 0.44 2833(v) 20.09.2013 fefy 326 Qsuk;Vksf;u lksfM;e xksfy;ka 50 fexzk- 1 xksyh 0.82 1570(v) 14.6.2013 327 Qsuk;Vksf;u lksfM;e dSilwy 100 fexzk- 1 dSilwy 1.61 1878(v) 28.06.201314 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 328 Qsuk;Vksf;u lksfM;e xksfy;ka 100 fexzk- 1 xksyh 1.51 1879(v) 28.06.2013 329 Qsuk;Vksf;u lksfM;e 50 fexzk-/ fefy 1 fefy 5.48 3329(v) 05.11.2013 bUtsD'ku 330 Qsuk;Vksf;u lksfM;e flji 100 fexzk- 1 fefy 0.82 3562(v) 02.12.2013 331 Qk;VksesukfM;ksu bUtsD'ku 10 fexzk-/ fefy 1 fefy 46.59 3343(v) 05.11.2013 332 fiyksdkjikbu Mªksi 2% 1 fefy 10.53 2862(v) 20.09.2013 333 fiizkt+kbu lksY;w'ku 750 fexzk-/5 1 fefy 0.30 2834(v) 20.09.2013 fefy 334 iksfyosysUV ,aVhLusd osue 10 fefy izfr iSd 436.51 2251(v) 22.07.2013 bUtsD'ku 335 iksVkf'k;e ijekUxkusV fØLVy - 1 xzke 0.40 3565(v) 02.12.2013 ds fy, lksY;w'ku 336 iksofMksu vk;ksfMu vkW;UVesUV 5% 1 xzke 1.74 1905(v) 28.06.2013 337 iksofMksu vk;ksfMu lksY;w'ku 5% 1 fefy 0.41 1651(v) 14.6.2013 338 iksofMksu vk;ksfMu lksY;w'ku 10% 1 fefy 0.97 1652(v) 14.6.2013 339 izsftDosUVy xksfy;ka 600 fexzk- 1 xksyh 25.38 3356(v) 05.11.2013 340 izkbekDohu xksfy;ka 2.5 fexzk- 1 xksyh 1.65 1821(v) 21.6.2013 341 izkbekDohu xksfy;ka 7.5 fexzk- 1 xksyh 2.11 1597(v) 14.6.2013 342 izksdkckZt+kbu dSilwy 50 fexzk- 1 dSilwy 33.64 3339(v) 05.11.2013 343 izksesFkkft+u flji@,fyDlj 5 fexzk-/ 5 1 fefy 0.22 1552(v) 14.6.2013 02.12.2013 fefy 3574(v) 344 izksesFkkft+u xksfy;ka 10 fexzk- 1 xksyh 0.99 2832(v) 20.09.2013 345 izksesFkkft+u xksfy;k 25 fexzk- 1 xksyh 2.65 1566(v) 14.6.2013 346 izksesFkkft+u bUtsD'ku 25 fexzk-/ fefy 1 fefy 3.18 1006(v) 02.04.2014 347 izksiksQksy bUtsD'ku 1% vkW;y 1 fefy 9.19 3566(v) 02.12.2013 lLisU'ku 348 Ikzksizkuksy gkbMªksDyksjkbM 10 fexzk- 1 xksyh 1.16 2240(v) 22.07.2013 xksfy;ka 349 Ikzksizkuksy gkbMªksDyksjkbM 40 fexzk- 1 xksyh 2.72 2528(v) 21.08.2013 xksfy;ka 350 izksVkfeu lYQsV bUtsD'ku 10 fexzk-/ fefy 1 fefy 9.48 1898(v) 28.06.2013 351 ik;jkft+ukekbM xksfy;ka 500 fexzk- 1 xksyh 4.01 1587(v) 14.6.2013 352 ik;jkft+ukekbM xksfy;ka 750 fexzk- 1 xksyh 7.35 1588(v) 14.6.2013 353 ik;jkft+ukekbM xksfy;ka 1000 fexzk- 1 xksyh 8.82 1589(v) 14.6.2013 354 ik;jkft+ukekbM xksfy;ka 1500 fexzk- 1 xksyh 10.40 2527(v) 21.08.2013 355 ik;fjMksfLVt+ekbu xksfy;ka 60 fexzk- 1 xksyh 13.49 1919(v) 28.06.2013¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 15 356 Dohfuu lYQsV xksfy;ka 300 fexzk- 1 xksyh 5.42 1598(v) 14.6.2013 357 Dohfuu lYQsV bUtsD'ku 300 fexzk-/ 1 fefy 9.64 1599(v) 14.6.2013 fefy 358 jsfcl osfDlu bUtsD'ku 150 vkbZ;w/ 1 fefy 1335.21 3350(v) 05.11.2013 fefy 359 jsfcl osfDlu bUtsD'ku izfr iSd 321.50 1672(v) 14.6.2013 360 jsyksDlhQsu xksfy;ka 60 fexzk- 1 xksyh 10.52 1616(v) 14.6.2013 361 fjaxj ysDVsV bUtsD'ku vkbZih ds 1 fefy 0.11 2863(v) 20.09.2013 vk/kkj ij 362 fjVksusfoj dSilwy 100 fexzk- 1 dSilwy 36.38 3360(v) 05.11.2013 363 Lsoks¶Y;wjsu bUgsys'ku 1 fefy 29.76 2850(v) 20.09.2013 364 lksfM;e ck;dkcksZusV vkbZih ds 1 fefy 1.35 2864(v) 20.09.2013 bUtsD'ku vk/kkj ij 365 lksfM;e ukbVªksfifj;kslkbM 50 fexzk-/ 5 izfr iSd 138.19 1902(v) 28.06.2013 bUtsD'ku fefy 366 lksfM;e LVhcksXywdksusV 100 fexzk-/ 1 fefy 3.47 3362(v) 05.11.2013 bUtsD'ku fefy 367 lksfM;e osyizks,sV xksfy;ka 200 fexzk- 1 xksyh 3.26 1571(v) 14.6.2013 368 lksfM;e osyizks,sV flji 200 fexzk-/5 1 fefy 0.62 1572(v) 14.6.2013 fefy 369 lksfM;e osyizks,sV bUtsD'ku 100 fexzk-/ 1 fefy 5.73 1880(v) 28.06.2013 fefy 370 lksfM;e osyizks,sV xksfy;ka 200 fexzk- 1 xksyh 3.26 1571(v) 14.6.2013 371 lksfM;e osyizks,sV xksfy;ka 500 fexzk- 1 xksyh 7.63 1911(v) 28.06.2013 372 LVsO;wMkbu dSilwy 30 fexzk- 1 dSilwy 2.92 2841(v) 20.09.2013 373 LVsO;wMkbu dSilwy 40 fexzk- 1 dSilwy 3.32 2842(v) 20.09.2013 374 LVsO;wMkbu$ysfe;wMkbu 30 fexzk-+ 1 xksyh 9.78 1593(v) 14.6.2013 xksfy;ka 150 fexzk- 375 LVªsIVksfdusl bUtsD'ku 750,000 vkbZ;w izfr iSd 1156.16 1644(v) 14.6.2013 376 LVªsIVksfdusl bUtsD'ku 15,00,000 izfr iSd 2162.59 1645(v) 14.6.2013 vkbZ;w 377 lDlhuk;y dksfyu DyksjkbM 50 fexzk-/ fefy 1 fefy 6.42 3765(v) 20.12.2013 bUtsD'ku 378 lYQsDVkekbM lksfM;e Mªksi 10% 1 fefy 2.46 3377(v) 05.11.2013 379 lYQsDVkekbM lksfM;e Mªksi 20% 1 fefy 2.48 3378(v) 05.11.2013 380 VseksDlhQsu lkbVªsV xksfy;ka 10 fexzk- 1 xksyh 4.62 1896(v) 28.06.2013 381 VseksDlhQsu lkbVªsV xksfy;ka 20 fexzk- 1 xksyh 2.95 1617(v) 14.6.2013 382 VsjC;wVkfyu lYQsV xksfy;ka 2.5 fexzk- 1 xksyh 1.04 1682(v) 14.6.201316 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 383 VsjC;wVkfyu lYQsV bUtsD'ku 0.5 fexzk-/ izfr iSd 9.30 3375(v) 05.11.2013 fefy 384 VsLVksLVsfj;ksu dSilwy 40 fexzk- 1 dSilwy 11.65 1659(v) 14.6.2013 vufMdsU;ks,sV ¼ ds leku ½ 385 VsVul VksDlkbM bUtsD'ku 1 fefy 10.94 1673(v) 14.6.2013 17.2.2014 431(v) 386 fFk;ksisUVksu lksfM;e bUtsD'ku 0.5xzke / iSd izfr iSd 44.30 1544(v) 14.6.2013 387 fFk;ksisUVksu lksfM;e bUtsD'ku 1 xzke ikmMj 1 xzke 49.84 3354(v) 05.11.2013 388 VkbZeksyksy esfy,sV Mªksi 0.25% 1 fefy 4.74 2252(v) 22.07.2013 389 VkbZeksyksy esfy,sV Mªksi 0.50% 1 fefy 12.83 2253(v) 22.07.2013 390 VªsekMksy bUtsD'ku 50 fexzk-/ fefy 1 fefy 12.47 2231(v) 22.07.2013 391 VªsekMksy dSilwy 50 fexzk- 1 dSilwy 6.51 1872(v) 28.06.2013 392 VªkbZgsDlhQsfuMk;y 2 fexzk- 1 xksyh 1.45 1619(v) 14.6.2013 gkbMªksDyksjkbM xksfy;ka 393 VªksfidkekbM vk¡[k dk Mªksi 1% 1 fefy 10.21 1650(v) 14.6.2013 394 ;wjksfdusl bUtsD'ku 500,000 izfr iSd 2648.40 3571(v) 02.12.2013 vkbZ;w/ fefy 395 osUdksekbflu gkbMªksDyksjkbM 500 fexzk- izfr iSd 351.49 1579(v) 14.6.2013 bUtsD'ku 396 osUdksekbflu gkbMªksDyksjkbM 1 xzke izfr iSd 546.95 1580(v) 14.6.2013 bUtsD'ku 397 foD;ksjksfu;e bUtsD'ku 2 fexzk-/ fefy izfr iSd 79.29 1920(v) 28.06.2013 398 fouCykfLVu lYQsV bUtsD'ku 10 fexzk-/ iSd izfr iSd 302.91 3340(v) 05.11.2013 399 foufØLVhu bUtsD'ku 1 fexzk-/ fefy izfr iSd 53.80 1613(v) 14.6.2013 400 osjkQsfju lksfM;e xksfy;ka 5 fexzk- 1 xksyh 2.38 1621(v) 14.6.2013 401 bUtsD'ku ds fy, ikuh 5 fefy 1 ,Ei;wy 3.67 2865(v) 20.09.2013 bUtsD'ku 402 bUtsD'ku ds fy, ikuh 10 fefy 1 ,Ei;wy 5.06 2866(v) 20.09.2013 bUtsD'ku 403 ft+MksO;wMkbu xksfy;ka 300 fexzk- 1 xksyh 15.92 1913(v) 28.06.2013 404 ft+MksO;wMkbu$ ysfe;wMkbu$ 300 fexzk- 1 xksyh 20.25 1594(v) 14.6.2013 usfojsikbu xksfy;ka +150 fexzk- +200 fexzk-¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 17 uksV % ¼d½ tSlk fd mi;qZDr vf/kdre dhersa 1 vizSy] 2014 ls izHkkoh gSA ¼[k½ mi;qZDr lkj.kh ds LraHk ¼5½ es vf/kdre [kqnjk dher gksus ds Åij mYysf[kr vuqlwfpr fofufeZfr;ksa ds fuekZrkvksa dks Mhihlhvks] 2013 ds iSjkxzkQ 13 ¼1½ vkSj iSjk 24 ds rgr vf/kdre dher ls vf/kd LFkkuh; dj] tgka dgh Hkh ykxw gks] ds vuqlkj vukf/kd vf/kd [kqnjk dher dks la'kksf/kr djsxkA ¼x½ vxj fuekZrkvksa us mi;qZDr lkj.kh ds LraHk (5) esa of.kZr vf/kdre dher ij ljdkj dks okLro esa Hkqxrku fd;k gS ;k ;g ns; gS rks os LFkkuh; djksa dks tksM+ ldrs gSA ¼?k½ vkS"k/k ¼ewY; fu;a=k.k½ vkns'k] 2013 ds iSjkxzkQ 11 esa fn, x, izko/kkuksa ds rgr fuekZrkvksa dks mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V vf/kdre dher ds vk/kkj ij vuqlwfpr fofufeZfr;ksa ds iSdksa ds fy, vf/kdre dher fu/kkZfjr djsaA fuekZrk vkS"k/k ¼ewY; fu;a=k.k½ vkns'k] 2013 ds iSjkxzkQ 24¼2½ ds rgr QkWeZ V esa ,d ewY; lwph tkjh djsaA ¼M-½ lHkh ekStwnk fuekZrkvksa dks mi;qZDr dfFkr vuqlwfpr fofufeZfr;ksa ds vf/kdre [kqnjk dher mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V vf/kdre dher LFkkuh; dj lfgr ls de gS rks] tgka dgh Hkh ykxw gks] vkS"k/k ¼ewY; fu;a=k.k½ vkns'k] 2013 ds iSjkxzkQ 13(2) ds vuqlkj mldks ekStwnk vf/kdre [kqnjk dher dks cuk, j[kuk gksxkA ¼p½ mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V vf/kdre dher ds fy, fofufnZ"V vuqlwfpr fofufeZfr;ksa ds fofufnZ"V fofHkUu rjhds vkSj izcyrk ls fHkUu vxj ekStwnk fuekZrkvksa }kjk ,d ubZ vkS"kf/k dks ykap djrk gS rks mls igys vkS"k/k ¼ewY; fu;a=k.k½ vkns'k] 2013 ds iSjkxzkQ 2¼u½ ds vuqlkj vkS"k/k ¼ewY; fu;a=k.k½ vkns'k] 2013 ds rgr lwph II esa fofufnZ"V QkeZ I ds ek/;e ls ,uihih, esa ewY; fu/kkZj.k gsrq vkosnu djuk gksxkA ¼N½ mi;qZDr vuqlwfpr fofufeZfr;ksa dh mRiknu@vk;kr vkSj fcØh ds lEcU/k esa fuekZrkvksa dks vkS"k/k ¼ewY; fu;a=k.k½ vkns'k] 2013 ds lwph II ds QkWeZ III esa Hkjdj ,uihih, dks gj frekgh dh fjiksVZ izLrqr djsxkA mi;qZDr vuqlwfpr fofufeZfr;ksa ds fuekZ.k dks dksbZ fuekZrk mRiknu cUn djus dk bPNqd gks rks bldh lwpuk ,uihih, dks voxr djk;sxkA blds lEcU/k esa vxj vuqlwfpr fofufeZfr;ksa ds mRiknu vkSj vk;kr dks cUn djus dk bPNqd gS rks cUn djus dh frfFk ls N% eghus igys lwph II ds QkWeZ IV esa Hkjdj ,uihih, dks izLrqr djsxkA ¼t½ fofuekZrk ;k foi.ku dEiuh] mijksDr dfFkr lkj.kh esa n'kkZ;s vf/kdre ewY; vkSj 'krks± dk ikyu ugha djrh gSa rks os vko';d oLrq,¡ vf/kfu;e] 1955 ds lkFk ifBr Mhihlhvks] 2013 ds izko/kkuksa ds v/khu C;kt lfgr vf/kizHkkfjr jkf'k dks tek djus ds fy, nk;h gksaxsA ¼>½ bl vkns'k esa mijksDr lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa fofufnZ"V vuqlwfpr fofufeZr;ksa ds iSdksa dh vf/kdre dher fu;r gksus ds ifj.kke Lo#i] vkns'k tks fd bl vkns'k ls iwoZ tkjh gq, gS] Lor% gh fujLr gks tk;saxsaA [dka-la-@146@14@2014@fo@Qk- la- 8¼14½@2014@Mhih@,uihih,-&fMoh— II] euh"k xksLokeh] mi&funs'kd18 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] MINISTRY OF CHEMICALS AND FERTILIZERS (Department of Pharmaceuticals) (NATIONAL PHARMACEUTICAL PRICING AUTHORITY) ORDER New Delhi, the 28th April, 2014 S.O. 1156(E).—In exercise of the powers, conferred by paragraph 4, 6, 10, 11, 14 and 16 of the Drugs (Prices Control) Order, 2013, read with S.O. No. 1394(E) dated the 30th May, 2013 issued by the Government of India in the Ministry of Chemicals and Fertilizers, and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers (National Pharmaceutical Pricing Authority) S.O. Number given in specified column no. 6 & 7 mentioned in the below, hereby fixes the prices as specified in column (5) of the table herein below as ceiling prices exclusive of local tax applicable, if any in respect of the Scheduled formulations specified in the corresponding entry in column (2) of the said Table with the strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof: TABLE Sr. Name of the Schedule Strengths Unit Ceiling S.O. No. Date No. Formulation Price (Rs.) 1 2 3 4 5 6 7 1 25% Dextrose Injection 100 ml 1 ml 0.17 2068(E) 05.07.2013 2 5- Fluorouracil Injection 250mg/ 5 ml 1 ml 2.21 3556(E) 02.12.2013 3 5-Amino salicylic Acid (5- 400mg 1 Tablet 9.14 1005(E) 02.04.2014 ASA) Tablets 4 Acetazolamide Tablets 250 mg 1 Tablet 3.92 1816(E) 21.6.2013 5 Acyclovir Tablets 200 mg 1 Tablet 7.76 1590(E) 14.6.2013 6 Acyclovir Tablets 400 mg 1 Tablet 12.38 1887(E) 28.06.2013 7 Acyclovir Injection 250 mg/pack Each Pack 489.13 2056(E) 05.07.2013 8 Acyclovir Injection 500 mg/pack Each Pack 461.23 3331(E) 05.11.2013 9 Acyclovir Suspension 400 mg / 5 ml 1 ml 1.40 2839(E) 20.09.2013 10 Acyclovir Cream 5% 1 gm 9.44 1812(E) 21.6.2013 11 Adenosine Injection 3 mg/ml 1 ml 121.79 1627(E) 14.6.2013 12 Adrenaline Bitartrate 1 mg / ml 1 ml 39.59 1565(E) 14.6.2013 Injection 13 Albendazole Tablets 400 mg 1 Tablet 9.70 1793(E) 21.6.2013 14 Albendazole Suspension 200 mg/ 5 ml 1 ml 1.57 1794(E) 21.6.2013 15 Albumin Injection 20% 1 ml 38.98 1807(E) 21.6.2013 16 Allopurinol Tablets 100 mg 1 Tablet 2.22 2830(E) 20.09.2013 17 Alpha Interferon Injection 3 million IU Each pack 807.71 1604(E) 14.6.2013 18 Alprazolam Tablets 0.25 mg 1 Tablet 1.02 1817(E) 21.6.2013 19 Alprazolam Tablets 0.5 mg 1 Tablet 2.14 1908(E) 28.06.2013 20 Amikacin Injection 250 mg / 2 ml 1 ml 14.84 1801(E) 21.6.2013 21 Amiodarone Tablets 100 mg 1 Tablet 6.93 1628(E) 14.6.2013 22 Amiodarone Tablets 200 mg 1 Tablet 12.41 1629(E) 14.6.2013 23 Amiodarone Injection 50 mg/ml 1 ml 22.07 1630(E) 14.6.2013 24 Amitriptyline Tablets 25 mg 1 Tablet 2.25 1686(E) 14.6.2013 25 Amlodipine Tablets 2.5 mg 1 Tablet 1.90 3772(E) 20.12.2013 26 Amlodipine Tablets 5 mg 1 Tablet 3.01 3773(E) 20.12.2013 27 Amoxicillin Powder for 125 mg / 5 ml 1 ml 0.61 1795(E) 21.6.2013 suspension¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 19 28 Amoxicillin Capsules 250 mg 1Capsule 2.93 2046(E) 05.07.2013 29 Amoxicillin Capsules 500 mg 1 Capsule 6.47 1796(E) 21.6.2013 30 Amoxicillin+Clavulinic acid 625 mg 1 Tablet 23.88 1881(E) 28.06.2013 Tablets 31 Amoxicillin+Clavulinic acid 228.5mg/5ml 1 gm 1.99 1882(E) 28.06.2013 Powder for suspension 32 Amoxicillin+Clavulinic acid 600mg/vial pack Each pack 91.39 1883(E) 28.06.2013 Injection 33 Amoxicillin+Clavulinic acid 1.2gm/vial pack Each pack 135.42 1884(E) 28.06.2013 Injection 34 Amphotericin B Injection 50 mg/vial pack Each pack 4513.62 1912(E) 28.06.2013 35 Ampicillin Capsules 250 mg 1Capsule 2.66 2047(E) 05.07.2013 36 Ampicillin Capsules 500 mg 1 Capsule 5.05 1797(E) 21.6.2013 37 Ampicillin Powder for 125 mg / 5 ml 1 ml 0.67 1575(E) 14.6.2013 suspension 38 Ampicillin Injection 500 mg each pack 14.25 1798(E) 21.6.2013 39 Anti-D immunoglobin 300 µg Each pack 2349.46 1670(E) 14.6.2013 (human) Injection 40 Antitetanus Human 250 IU/pack Each Pack 884.75 3371(E) 05.11.2013 immunoglobin Injection 41 Antitetanus Human 500 IU/pack Each Pack 1474.90 3372(E) 05.11.2013 immunoglobin Injection 42 Artesunate (To be used only 50 mg 1 Tablet 21.31 1802(E) 21.6.2013 in combination with Sulfadoxine +Pyrimethamine) Tablets 43 Atenolol Tablets 50 mg 1 Tablet 2.20 1810(E) 21.6.2013 44 Atenolol Tablets 100 mg 1 Tablet 3.96 1632(E) 14.6.2013 45 Atorvastatin Tablets 5 mg 1 Tablet 4.06 1647(E) 14.6.2013 46 Atorvastatin Tablets 10 mg 1 Tablet 6.28 1811(E) 21.6.2013 47 Atracurium besylate 10 mg / ml Each pack 48.14 1674(E) 14.6.2013 Injection 48 Atropine Sulphate Injection 0.6 mg / ml 1 ml 4.26 1548(E) 14.6.2013 49 Atropine Sulphate Drops 1% 1 ml 3.09 1830(E) 21.6.2013 50 Atropine Sulphate Ointment 1% 1 gm 3.44 1831(E) 21.6.2013 51 Azathioprine Tablets 50 mg 1 Tablet 10.52 1560(E) 14.6.2013 52 Azithromycin Tablets 100mg 1 Tablet 5.45 2051(E) 05.07.2013 53 Azithromycin Tablets 250mg 1 Tablet 10.91 2052(E) 05.07.2013 54 Azithromycin Tablets 500mg 1 Tablet 21.81 3379(E) 05.11.2013 55 Azithromycin Suspension 100mg/5ml 1 ml 1.65 2237(E) 22.07.2013 56 Azithromycin Injection 500mg Each Pack 193.79 1578(E) 14.6.2013 57 Beclomethasone 50 µg/dose 1 Inhaler 180.07 2846(E) 20.09.2013 Dipropionate Inhalation 58 Beclomethasone 250µg/ MT dose Each Mt 1.62 1690(E) 14.6.2013 Dipropionate Inhalation Dose 59 Benzoin Compound 1 ml 0.34 3561(E) 02.12.2013 Tincture 60 Benzyl Benzoate Lotion 25% 1 ml 0.15 3560(E) 02.12.2013 61 Betaxolol Hydrochloride 0.25% 1 ml 4.24 3374(E) 05.11.2013 Drops 62 Betaxolol Hydrochloride 0.50% 1 ml 7.01 1677(E) 14.6.201320 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] Drops 63 Bisacodyl Tablets 5 mg 1 Tablet 1.03 2065(E) 05.07.2013 64 Bisacodyl Suppository 5 mg 1 8.47 3369(E) 05.11.2013 Suppository 65 Bleomycin Injection 15 mg 1 ml 654.99 1605(E) 14.6.2013 66 Bromocriptine Mesylate 1.25 mg 1 Tablet 8.06 1805(E) 21.6.2013 Tablets 67 Bromocriptine Mesylate 2.5 mg 1 Tablet 14.46 1806(E) 21.6.2013 Tablets 68 Bupivacaine Hydrochloride 0.25% 1 ml 2.46 2851(E) 20.09.2013 Injection 69 Bupivacaine Hydrochloride 0.5% 1 ml 3.71 2852(E) 20.09.2013 Injection 70 Bupivacaine Hydrochloride 0.5% to be mixed 1 ml 6.09 2853(E) 20.09.2013 Injection with 7.5% glucose solution 71 Busulphan Tablets 2 mg 1 Tablet 3.63 3363(E) 05.11.2013 72 Calamine Lotion 1ml/gm 1.03 2859(E) 20.09.2013 73 Calcium carbonate Tablets 250 mg 1 Tablet 1.79 2867(E) 20.09.2013 74 Calcium carbonate Tablets 500 mg 1 Tablet 1.78 2255(E) 22.07.2013 75 Calcium gluconate Injection 100mg/ml in 10 ml 10 ml 10.58 2868(E) 20.09.2013 ampoule Ampoule 76 Carbimazole Tablets 5mg 1 Tablet 1.88 1668(E) 14.6.2013 77 Carbimazole Tablets 10mg 1 Tablet 3.65 1669(E) 14.6.2013 78 Carboplatin Injection 150 mg /vial pack each pack 838.88 1895(E) 28.06.2013 79 Carboplatin Injection 450mg/ vial each pack 2578.19 1916(E) 28.06.2013 80 Cefixime Tablet 100mg 1 Tablet 8.18 1820(E) 21.6.2013 81 Cefixime Tablet 200mg 1 Tablet 11.96 2236(E) 22.07.2013 82 Ceftazidime Injection 250mg Each Pack 67.41 1576(E) 14.6.2013 83 Ceftazidine Injection 1g each pack 243.67 1799(E) 21.6.2013 84 Ceftriaxone Injection 250mg each pack 26.15 1800(E) 21.6.2013 85 Ceftriaxone Injection 1g Each Pack 58.94 2235(E) 22.07.2013 86 Cephalexin Syrup 125 mg /5ml 1 ml 0.97 2050(E) 05.07.2013 87 Cephalexin Capsules 250 mg 1Capsule 5.58 2048(E) 05.07.2013 88 Cephalexin Capsules 500 mg 1Capsule 12.39 2049(E) 05.07.2013 89 Cetrimide Solution 20% (conc. for 1 ml 0.46 2249(E) 22.07.2013 dilution) 90 Cetrizine Tablets 10mg 1 Tablet 1.92 1875(E) 28.06.2013 91 Cetrizine Syrup 5 mg/ml 1 ml 0.57 1876(E) 28.06.2013 92 Chlorambucil Tablets 2 mg 1 Tablet 48.08 3342(E) 05.11.2013 93 Chloramphenicol Drops 1% 1 ml 4.53 3353(E) 05.11.2013 94 Chloramphenicol Ointment 1% 1 gm 4.53 2070(E) 05.07.2013 95 Chlorpheniramine Maleate 4 mg 1 Tablet 0.11 2232(E) 22.07.2013 Tablets 96 Cisplatin Injection 10 mg Each Pack 90.20 2241(E) 22.07.2013 97 Cisplatin Injection 50mg /vial pack each pack 320.30 1890(E) 28.06.2013 98 Clindamycin Tablet 300mg 1 Tablet 13.92 3332(E) 05.11.2013 99 Clofazimine Capsules 50 mg 1 Capsule 1.36 1581(E) 14.6.2013 100 Clofazimine Capsules 100 mg 1 Capsule 2.36 1582(E) 14.6.2013 101 Clomiphene citrate Tablets 50mg 1 Tablet 8.43 1906(E) 28.06.2013 102 Clomiphene citrate Tablets 100mg 1 Tablet 12.95 1664(E) 14.6.2013¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 21 103 Clopidogrel Tablets 75 mg 1 Tablet 10.66 2060(E) 05.07.2013 104 Clotrimazole Pessaries 100 mg 1 Pessaries 9.24 423(E) 17.02.2014 105 Clotrimazole Pessaries 200 mg 1 Pessaries 14.15 922(E) 27.03.2014 106 Clotrimazole Pessaries Gel 2% 1 gm 2.20 1886(E) 28.06.2013 107 Colchicine Tablets 0.5 mg 1 Tablet 3.06 1559(E) 14.6.2013 108 Condoms 1 Condom 6.97 3348(E) 05.11.2013 109 Cyclophosphamide Tablets 50 mg 1 Tablet 3.99 1606(E) 14.6.2013 110 Cyclophosphamide 500 mg 1 Injectable 77.31 2529(E) 21.08.2013 Injection 111 Cyclosporine Capsules 25 mg 1 Capsule 26.31 1602(E) 14.6.2013 112 Cyclosporine Capsules 50 mg 1 Capsule 51.31 1603(E) 14.6.2013 113 Cyclosporine Capsules 100 mg 1 Capsule 113.01 1889(E) 28.06.2013 114 Cyclosporine Concentrate 100 mg/ml 1 ml 126.14 3333(E) 05.11.2013 for Injection 115 Cytosine arabinoside 100 mg/vial each pack 253.51 1914(E) 28.06.2013 Injection 116 Cytosine arabinoside 500 mg/vial each pack 548.11 1891(E) 28.06.2013 Injection 117 Cytosine arabinoside 1000 mg/vial each pack 1244.60 1892(E) 28.06.2013 Injection 118 D.P.T Vaccine Injection 1 Vial 247.58 1671(E) 14.6.2013 119 Dacarbazine Injection 500 mg Each pack 1094.13 1614(E) 14.6.2013 120 Danazol Capsules 50 mg 1 Capsule 9.96 1607(E) 14.6.2013 121 Danazol Capsules 100 mg 1 Capsule 21.61 1608(E) 14.6.2013 122 Dapsone Tablets 50 mg 1 Tablet 0.21 2835(E) 20.09.2013 123 Dapsone Tablets 100mg 1 Tablet 0.23 2836(E) 20.09.2013 124 Daunorubicin Injection 20 mg vial/pack Each Pack 376.04 3341(E) 05.11.2013 125 Desferrioxamine mesylate 500mg Each Pack 158.03 3355(E) 05.11.2013 Injection 126 Dexchlorpheniramine 0.5 mg / 5 ml 1 ml 0.32 2831(E) 20.09.2013 Maleate Syrup 127 Dextran-40 Injection 10% 1 ml 0.80 3344(E) 05.11.2013 128 Diazepam Injection 5 mg / ml 1 ml 5.94 1549(E) 14.6.2013 129 Diazepam Tablets 2 mg 1 Tablet 1.53 2533(E) 21.08.2013 130 Diazepam Tablets 5mg 1 Tablet 1.40 1832(E) 21.6.2013 131 Diclofenac Tablets 50 mg 1 Tablet 2.07 1909(E) 28.06.2013 132 Diclofenac Injection 25 mg / ml 1 ml 1.58 2869(E) 20.09.2013 133 Dicyclomine Hydrochloride 10 mg / ml 1 ml 3.14 2064(E) 05.07.2013 Injection 134 Didanosine Tablets 250 mg 1 Tablet 25.44 2840(E) 20.09.2013 135 Diethylcarbamazine citrate 50 mg 1 Tablet 0.50 1574(E) 14.6.2013 Tablets 136 Digoxin Tablets 0.25 mg 1 Tablet 1.34 1641(E) 14.6.2013 137 Digoxin Injection 0.25 mg/ml 1 ml 3.98 422(E) 17.02.2014 138 Dihydroergotamine Tablets 1 mg 1 Tablet 17.77 1601(E) 14.6.2013 139 Diloxanide Furoate Tablets 500 mg 1 Tablet 1.71 3361(E) 05.11.2013 140 Diltiazem Tablets 30 mg 1 Tablet 2.41 1622(E) 14.6.2013 141 Diltiazem Tablets 60 mg 1 Tablet 5.09 1899(E) 28.06.2013 142 Diltiazem Injection 5 mg/ ml 1 ml 3.21 2843(E) 20.09.2013 143 Diphtheria Antitoxin 10,000 IU/pack Each Pack 1229.06 3349(E) 05.11.2013 Injection22 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 144 Dobutamine Injection 50 mg / ml Each pack 69.55 1642(E) 14.6.2013 145 Domperidone Tablets 10 mg 1 Tablet 2.40 2063(E) 05.07.2013 146 Domperidone Syrup 1 mg / ml 1 ml 1.10 1654(E) 14.6.2013 147 Dopamine Hydrochloride 40 mg / ml 1 ml 5.88 1643(E) 14.6.2013 Injection 2536(E) 21.8.2013 148 Doxorubicin Injection 10 mg/ vial pack each pack 208.90 1893(E) 28.06.2013 149 Doxorubicin Injection 50 mg Each Pack 1217.58 1609(E) 14.6.2013 150 Efavirenz Capsules 200 mg 1 Capsule 24.62 3359(E) 05.11.2013 151 EMLA Cream 1 gm 21.35 1547(E) 14.6.2013 152 Enalapril Maleate Tablets 2.5 mg 1 Tablet 1.89 1633(E) 14.6.2013 153 Enalapril Maleate Tablets 5mg 1 Tablet 3.15 1634(E) 14.6.2013 154 Enoxaparin Injection 40mg Each Pack 467.16 2246(E) 22.07.2013 155 Enoxaparin Injection 60mg/pack each pack 564.54 1917(E) 28.06.2013 156 Esmolol Injection 10 mg / ml 1 ml 21.81 1631(E) 14.6.2013 157 Ethambutol Tablets 200 mg 1 Tablet 1.03 2837(E) 20.09.2013 158 Ethambutol Tablets 400 mg 1 Tablet 2.31 1583(E) 14.6.2013 159 Ethambutol Tablets 600 mg 1 Tablet 3.35 1584(E) 14.6.2013 160 Ethambutol Tablets 800 mg 1 Tablet 3.98 1585(E) 14.6.2013 161 Ethinylestradiol Tablets 0.01mg 1 Tablet 2.25 1660(E) 14.6.2013 162 Ethinylestradiol Tablets 0.05mg 1 Tablet 3.75 3370(E) 05.11.2013 163 Ethinylestradiol + 0.03 mg +0.15 mg 1 Tablet 3.24 2067(E) 05.07.2013 Levonorgesterol Tablets 164 Ethyl Alcohol 70% Solution - 1ml 0.52 3766(E) 20.12.2013 165 Etoposide Capsules 100 mg 1 Capsule 55.61 3364(E) 05.11.2013 166 Etoposide Injection 100 mg/ 5 ml vial each pack 204.55 1915(E) 28.06.2013 167 Factor VIII Concentrate Dried Each Pack 6464.71 3345(E) 05.11.2013 Injection 168 Fentanyl Injection 50 mcg/ml 1 ml 21.54 1558(E) 14.6.2013 169 Filgrastim Injection 1 ml 2278.21 1897(E) 28.06.2013 170 Fluconazole Capsules 50 mg 1 Capsule 10.80 1822(E) 21.6.2013 171 Fluconazole Tablets 50 mg 1 Tablet 8.32 1823(E) 21.6.2013 172 Fluconazole Capsules 100 mg 1Capsule 25.31 2849(E) 20.09.2013 173 Fluconazole Tablets 100 mg 1 Tablet 15.05 1824(E) 21.6.2013 174 Fluconazole Capsules 150 mg 1Capsule 25.08 2054(E) 05.07.2013 175 Fluconazole Tablet 150 mg 1 Tablet 15.36 2055(E) 05.07.2013 176 Fluconazole Capsules 200 mg 1 Capsule 41.37 1825(E) 21.6.2013 177 Fluconazole Tablets 200 mg 1 Tablet 27.49 1826(E) 21.6.2013 178 Fluoxetine hydrochloride 20 mg 1 Capsule 3.69 1922(E) 28.06.2013 Capsules 179 Flutamide Tablet 250 mg 1 Tablet 9.16 1894(E) 28.06.2013 180 Folic Acid Tablets 1 mg 1 Tablet 0.27 3365(E) 05.11.2013 181 Folic Acid Tablets 5mg 1 Tablet 1.46 3570(E) 02.12.2013 182 Gemcitabine hydrochloride 200 mg Each Pack 1387.33 1610(E) 14.6.2013 Injection 183 Gemcitabine hydrochloride 1 gm Each Pack 6346.41 1611(E) 14.6.2013 Injection 184 Gentian Violet Paint 1% 1ml 0.06 3767(E) 20.12.2013 185 Glibenclamide Tablets 2.5 mg 1 Tablet 0.51 1661(E) 14.6.2013 186 Glibenclamide Tablets 5mg 1 Tablet 1.02 1662(E) 14.6.2013 187 Glucagon Injection 1mg/ml Each pack 838.15 1663(E) 14.6.2013 188 Glucose Injection 10% 1 ml 0.05 1819(E) 21.6.2013¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 23 189 Glutaraldehyde Solution 2% 1 ml 0.09 2860(E) 20.09.2013 190 Glycerin Solution 1 ml 0.31 3559(E) 02.12.2013 191 Glyceryl Trinitrate 0.5 mg 1 Tablet 1.97 1623(E) 14.6.2013 Sublingual Tablets 192 Glyceryl Trinitrate Injection 5mg/ml 1 ml 8.01 1624(E) 14.6.2013 193 Haloperidol Injection 5mg/ml 1 ml 5.99 1683(E) 14.6.2013 194 Halothane with vaporizer 1 ml 6.24 1542(E) 14.6.2013 Inhalation 195 Heparin Sodium Injection 5000 IU/ ml 1 ml 43.19 2858(E) 20.09.2013 196 Heparin Sodium Injection 1000 IU/ml 1 ml 18.61 3764(E) 20.12.2013 197 Hepatitis B Vaccine 1 ml 107.48 3351(E) 05.11.2013 Injection 198 Homatropine Drops 2% 1 ml 5.78 3573(E) 02.12.2013 199 Hydrochlorthiazide Tablets 12.5 mg 1 Tablet 1.03 1639(E) 14.6.2013 200 Hydrochlorthiazide Tablets 25 mg 1 Tablet 1.76 1640(E) 14.6.2013 201 Hydrocortisone Sodium 100 mg Each Pack 39.48 2233(E) 22.07.2013 Succinate Injection 202 Hydrocortisone sodium 200mg 1 ml 75.97 2847(E) 20.09.2013 succinate Injection 203 Hydrocortisone sodium 400 mg Each pack 144.28 1691(E) 14.6.2013 succinate Injection 204 Hydrogen Peroxide 6% 1ml 0.05 3768(E) 20.12.2013 Solution 205 Hydroxychloroquine 200 mg 1 Tablet 6.00 1563(E) 14.6.2013 phosphate/ Sulphate Tablets 206 Hydroxyethyl Starch 6% 1 ml 0.79 3366(E) 05.11.2013 (Hetastarch) Injection 207 Hyoscine Butyl Bromide 10 mg 1 Tablet 3.01 3347(E) 05.11.2013 Tablets 208 Hyoscine Butyl Bromide 20 mg / ml 1 ml 10.46 1658(E) 14.6.2013 Injection 209 Ifosfamide Injection 1 gm/ 2ml vial Each Pack 366.68 3558(E) 02.12.2013 430(E) 17.02.2014 210 Imatinib Tablets 100 mg 1 Tablet 93.13 1827(E) 21.06.2013 211 Imatinib Tablets 400 mg 1 Tablet 285.29 1615(E) 14.6.2013 212 Imipramine Tablets 25 mg 1 Tablet 0.80 1687(E) 14.6.2013 213 Imipramine Tablets 75 mg 1 Tablet 2.13 1688(E) 14.6.2013 214 Indinavir Capsules 400 mg 1 capsule 20.64 1596(E) 14.6.2013 215 Ipratropium bromide 20µg/metered dose 1 MT Dose 0.72 2848(E) 20.09.2013 Inhalation 216 Iron Dextran Injection 50 mg iron/ml 1 ml 30.52 2245(E) 22.07.2013 217 Isoflurane Inhalation 1 ml 11.41 2230(E) 22.07.2013 218 Isoniazid Tablets 100 mg 1 Tablet 0.77 2838(E) 20.09.2013 219 Isoniazid Tablets 300 mg 1 Tablet 1.35 2238(E) 22.07.2013 220 Isoniazid Syrup 100 mg/5ml 1 ml 0.23 3357(E) 05.11.2013 221 Isosorbide 5 Mononitrate 10 mg 1 Tablet 2.04 1625(E) 14.6.2013 Tablets 222 Isosorbide 5 Mononitrate 20 mg 1 Tablet 3.50 1626(E) 14.6.2013 Tablets 223 Isosorbide Dinitrate Tablets 10 mg 1 Tablet 0.73 2057(E) 05.07.2013 224 Ispaghula Granules 1 gm 0.81 1813(E) 21.6.201324 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 225 Ketamine Hydrochloride 50 mg / ml 1 ml 11.12 1543(E) 14.6.2013 Injection 226 L- Asparaginase Injection 5000 KU./pack Each Pack 1258.74 3334(E) 05.11.2013 227 Lamivudine Tablets 150 mg 1 Tablet 9.99 1888(E) 28.06.2013 228 Lamivudine + Nevirapine + 150 mg + 200 mg+ 1 Tablet 18.38 1591(E) 14.6.2013 Stavudine Tablets 30 mg 229 Lamivudine + Zidovudine 150 mg + 300 mg 1 Tablet 20.87 1592(E) 14.6.2013 Tablets 230 Leflunomide Tablets 10mg 1 Tablet 16.05 1874(E) 28.06.2013 231 Leflunomide Tablets 20 mg 1 Tablet 30.44 1564(E) 14.6.2013 232 Levothyroxine Tablets 50µg 1 Tablet 1.07 2069(E) 05.07.2013 233 Levothyroxine Tablets 100 µg 1 Tablet 1.18 1815(E) 21.6.2013 234 Lignocaine Hydrochloride 2-5% 1ml/gm 1.25 2854(E) 20.09.2013 Topical Forms 235a Lignocaine Hydrochloride 1% Each Pack 7.30 3376(E) 05.11.2013 Injection 235b Lignocaine Hydrochloride 2% 1 ml 1.06 2248(E) 22.07.2013 Injection 236 Lignocaine Hydrochloride + 1%+1:200,000/pack Each Pack 0.72 1546(E) 14.6.2013 Adrenaline Injection 237 Lignocaine Hydrochloride + 2% + 1 ml 0.98 923(E) 27.03.2014 Adrenaline Injection Adrenaline1:200,000 238 Lithium Carbonate Tablets 300 mg 1 Tablet 1.50 1689(E) 14.6.2013 239 Lorazepam Injection 2mg/ml 1 ml 7.86 1573(E) 14.6.2013 240 Losartan Potassium Tablets 25 mg 1 Tablet 2.66 1635(E) 14.6.2013 241 Losartan Potassium Tablets 50 mg 1 Tablet 4.57 1636(E) 14.6.2013 242 Magnesium sulphate 500 mg /ml 1 ml 5.27 3328(E) 05.11.2013 Injection 243 Mannitol Injection 10% 1 ml 0.24 3572(E) 02.12.2013 244 Mannitol Injection 20% 1 ml 0.37 2062(E) 05.07.2013 245 Measles Vaccine Injection Each Pack 268.96 3352(E) 05.11.2013 246 Medroxy Progesterone 5mg 1 Tablet 2.75 1665(E) 14.6.2013 Acetate Tablets 247 Medroxy Progesterone 10mg 1 Tablet 5.57 1666(E) 14.6.2013 Acetate Tablets 248 Mefloquine Tablet 250 mg base 1 Tablet 53.22 1600(E) 14.6.2013 249 Melphalan Tablet 2 mg 1 Tablet 115.39 3335(E) 05.11.2013 250 Melphalan Tablet 5 mg 1 Tablet 193.57 3336(E) 05.11.2013 251 Mercaptopurine Tablet 50 mg 1 Tablet 9.49 3337(E) 05.11.2013 252 Mesna Injection 200 mg 1 ml 26.12 2243(E) 22.07.2013 253 Metformin Tablets 500mg 1 Tablet 1.66 1814(E) 21.6.2013 254 Methotrexate Tablets 5mg 1 Tablet 8.08 1561(E) 14.6.2013 255 Methotrexate Tablets 7.5mg 1 Tablet 11.98 1562(E) 14.6.2013 256 Methotrexate Tablets 10mg 1 Tablet 14.83 1873(E) 28.06.2013 257 Methotrexate Tablet 2.5 mg 1 Tablet 5.02 1612(E) 14.6.2013 258 Methotrexate Injection 50 mg / ml 1 ml 35.28 2242(E) 22.07.2013 259 Methyl Ergometrine Tablets 0.125mg 1 Tablet 7.59 1679(E) 14.6.2013 260 Methyl Ergometrine 0.2mg/ml 1ml 14.26 3769(E) 20.12.2013 Injection 261 Methyl Prednisolone 40 mg/ ml 1 ml 66.49 2066(E) 05.07.2013 Injection¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 25 262 Metoclopramide Tablets 10 mg 1 Tablet 1.11 1655(E) 14.6.2013 263 Metoclopramide Syrup 5 mg / 5 ml 1 ml 0.50 1656(E) 14.6.2013 264 Metoclopramide Injection 5 mg / ml 1 ml 2.22 1657(E) 14.6.2013 265 Metoprolol Tablets 25 mg 1 Tablet 3.59 3770(E) 20.12.2013 266 Metoprolol Tablets 50 mg 1 Tablet 5.33 3771(E) 20.12.2013 267 Metoprolol Injection 1mg/ml 1 ml 2.77 2247(E) 22.07.2013 268 Miconazole Ointment 2% 1 gm 2.33 1903(E) 28.06.2013 269 Miconazole Cream 2% 1 gm 1.48 1904(E) 28.06.2013 270 Midazolam Injection 1 mg / ml 1 ml 6.16 1550(E) 14.6.2013 271 Midazolam Injection 5 mg / ml 1 ml 26.35 1551(E) 14.6.2013 272 Mifepristone Tablets 200mg 1 Tablet 379.70 2254(E) 22.07.2013 273 Misoprostol Tablets 100ug 1 Tablet 10.03 1681(E) 14.6.2013 274 Mitomycin- C Injection 10 mg Each Pack 422.70 3557(E) 02.12.2013 275 Morphine Sulphate Injection 10 mg / ml 1 ml 22.88 2856(E) 20.09.2013 276 Morphine Sulphate Tablets 10 mg 1 Tablet 5.36 2857(E) 20.09.2013 277 N-acetylcysteine Injection 200 mg/ml 1 ml 23.94 1568(E) 14.6.2013 278 Naloxone Injection 0.4mg/ml 1 ml 97.29 2234(E) 22.07.2013 279 Neostigmine Tablets 15 mg 1 Tablet 4.92 3373(E) 05.11.2013 280 Neostigmine Injection 0.5mg/ml 1 ml 4.30 1675(E) 14.6.2013 2537(E) 21.8.2013 281 Nevirapine Suspension 50 mg / 5 ml 1 ml 1.04 1595(E) 14.6.2013 282 Nifedipine Capsules 5 mg 1 Capsule 0.91 1900(E) 28.06.2013 283 Nifedipine Capsules 10mg 1 Capsule 1.25 1637(E) 14.6.2013 284 Nifedipine Tablets 10mg 1 Tablet 1.20 1638(E) 14.6.2013 285 Nifedipine Sustained release 10mg 1 Tablet 1.51 1901(E) 28.06.2013 tablets 286 Nifedipine Sustained release 10mg 1 Capsule 1.78 2844(E) 20.09.2013 capsules 287 Nifedipine Sustained release 20mg 1 Tablet 2.02 2061(E) 05.07.2013 tablets 288 Nifedipine Sustained release 20mg 1 Capsule 2.33 2845(E) 20.09.2013 capsules 289 Nifedipine Tablet 20 mg 1 Tablet 0.34 3563(E) 02.12.2013 290 Nitrofurantoin Tablets 100 mg 1 Tablet 7.31 1885(E) 28.06.2013 291 Nitrous Oxide Inhalation - Cubic 219.21 3762(E) 20.12.2013 Meter 292 Norethisterone Tablets 5mg 1 Tablet 5.39 1667(E) 14.6.2013 293 Ofloxacin Tablets 100 mg 1 Tablet 3.51 2053(E) 05.07.2013 294 Ofloxacin Tablets 200 mg 1 Tablet 5.21 2239(E) 22.07.2013 295 Ofloxacin Syrup 50 mg / 5 ml 1 ml 0.71 1586(E) 14.6.2013 296 Olanzapine Tablets 5mg 1 Tablet 3.08 1684(E) 14.6.2013 297 Olanzapine Tablets 10mg 1 Tablet 5.66 1685(E) 14.6.2013 298 Omeprazole Capsules 10 mg 1 Capsule 2.93 1828(E) 21.6.2013 299 Omeprazole Capsules 20 mg 1 Capsule 3.21 1829(E) 21.6.2013 300 Omeprazole Capsules 40 mg 1 Capsule 6.51 3346(E) 05.11.2013 301 Ondansetron Tablets 4 mg 1 Tablet 5.06 2244(E) 22.07.2013 302 Ondansetron Tablets 8 mg 1 Tablet 11.77 1618(E) 14.6.2013 303 Ondansetron Injection 2 mg/ml 1 ml 7.84 1803(E) 21.6.2013 304 Ondansetron Syrup 2 mg/5 ml 1 ml 1.11 1804(E) 21.6.2013 305 Oral Poliomyelitis vaccine 1 ml 106.21 3774(E) 20.12.2013 (LA) Solution26 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 306 Oral Rehydration Salts As per I.P 1 Gram 0.89 2531(E) 21.08.2013 Powder for solution 307 Oxaliplatin Injection 50 mg vial 1 Injectable 3182.43 2530(E) 21.08.2013 308 Oxygen Inhalation - Cubic 16.81 3763(E) 20.12.2013 Meter 309 Oxytocin Injection 5 IU/ ml 1 ml 17.26 1921(E) 28.06.2013 310 Oxytocin Injection 10IU/ml 1 ml 40.08 1680(E) 14.6.2013 311 Paclitaxel Injection 30 mg / 5 ml Each Pack 320.28 3338(E) 05.11.2013 312 Pantoprazole Injection 40 mg Each pack 50.96 1653(E) 14.6.2013 313 Paracetamol Injection 150 mg / ml 1 ml 3.65 3567(E) 02.12.2013 314 Paracetamol Syrup 125 mg / 5ml 1 ml 0.34 421(E) 17.02.2014 315 Paracetamol Tablets 500 mg 1 Tablet 1.00 1555(E) 14.6.2013 316 Paracetamol Suppository 80 mg 1 7.40 3568(E) 02.12.2013 Suppository 317 Paracetamol Suppository 170 mg 1 8.58 3569(E) 02.12.2013 Suppository 318 Penicillamine Capsules 250 mg 1 Capsule 13.95 1567(E) 14.6.2013 319 Permethrin Cream 5% 1 gm 1.88 1648(E) 14.6.2013 320 Permethrin Lotion 5% 1 ml 1.14 1649(E) 14.6.2013 321 Permethrin Lotion 1% 1 gm 0.96 3564(E) 02.12.2013 322 Phenobarbitone Tablets 30 mg 1 Tablet 0.99 1877(E) 28.06.2013 323 Phenobarbitone Tablets 60 mg 1 Tablet 1.80 1569(E) 14.6.2013 324 Phenobarbitone Injection 200 mg/ml 1 ml 19.94 2526(E) 21.08.2013 325 Phenobarbitone Syrup 20 mg/5ml 1 ml 0.44 2833(E) 20.09.2013 326 Phenytoin Sodium Tablets 50 mg 1 Tablet 0.82 1570(E) 14.6.2013 327 Phenytoin Sodium Capsules 100 mg 1 Capsule 1.61 1878(E) 28.06.2013 328 Phenytoin Sodium Tablets 100 mg 1 Tablet 1.51 1879(E) 28.06.2013 329 Phenytoin Sodium Injection 50 mg/ml 1 ml 5.48 3329(E) 05.11.2013 330 Phenytoin Sodium Syrup 100 mg 1 ml 0.82 3562(E) 02.12.2013 331 Phytomenadione Injection 10 mg/ml 1 ml 46.59 3343(E) 05.11.2013 332 Pilocarpine Drops 2% 1 ml 10.53 2862(E) 20.09.2013 333 Piperazine Solution 750mg/5ml 1 ml 0.30 2834(E) 20.09.2013 334 Polyvalent Antisnake 10 ml Each Pack 436.51 2251(E) 22.07.2013 Venom Injection 335 Potassium Permanganate - 1 gm 0.40 3565(E) 02.12.2013 Crystals for Solution 336 Povidone Iodine Ointment 5% 1 gm 1.74 1905(E) 28.06.2013 337 Povidone Iodine Solution 5% 1 ml 0.41 1651(E) 14.6.2013 338 Povidone Iodine Solution 10% 1 ml 0.97 1652(E) 14.6.2013 339 Praziquantel Tablets 600 mg 1 Tablet 25.38 3356(E) 05.11.2013 340 Primaquine Tablets 2.5 mg 1 Tablet 1.65 1821(E) 21.6.2013 341 Primaquine Tablets 7.5 mg 1 Tablet 2.11 1597(E) 14.6.2013 342 Procarbazine Capsules 50 mg 1 Capsule 33.64 3339(E) 05.11.2013 343 Promethazine Syrup/Elixir 5 mg / 5 ml 1 ml 0.22 1552(E) 14.6.2013 3574(E) 02.12.2013 344 Promethazine Tablets 10 mg 1 Tablet 0.99 2832(E) 20.09.2013 345 Promethazine Tablets 25 mg 1 Tablet 2.65 1566(E) 14.6.2013 346 Promethazine Injection 25 mg / ml 1 ml 3.18 1006(E) 02.04.2014 347 Propofol Injection 1% oil suspension 1 ml 9.19 3566(E) 02.12.2013 348 Propranolol hydrochloride 10 mg 1 Tablet 1.16 2240(E) 22.07.2013 Tablets¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 27 349 Propranolol hydrochloride 40 mg 1 Tablet 2.72 2528(E) 21.08.2013 Tablets 350 Protamine Sulphate 10 mg/ml 1 ml 9.48 1898(E) 28.06.2013 Injection 351 Pyrazinamide Tablets 500 mg 1 Tablet 4.01 1587(E) 14.6.2013 352 Pyrazinamide Tablets 750 mg 1 Tablet 7.35 1588(E) 14.6.2013 353 Pyrazinamide Tablets 1000 mg 1 Tablet 8.82 1589(E) 14.6.2013 354 Pyrazinamide Tablets 1500 mg 1 Tablet 10.40 2527(E) 21.08.2013 355 Pyridostigmine Tablets 60 mg 1 Tablet 13.49 1919(E) 28.06.2013 356 Quinine sulphate Tablets 300 mg 1 Tablet 5.42 1598(E) 14.6.2013 357 Quinine sulphate Injection 300 mg / ml 1 ml 9.64 1599(E) 14.6.2013 358 Rabies immunoglobin 150 IU / ml 1 ml 1335.21 3350(E) 05.11.2013 Injection 359 Rabies Vaccine Injection Each pack 321.50 1672(E) 14.6.2013 360 Raloxifene Tablets 60 mg 1 Tablet 10.52 1616(E) 14.6.2013 361 Ringer Lactate Injection As per IP 1 ml 0.11 2863(E) 20.09.2013 362 Ritonavir Capsules 100 mg 1 Capsule 36.38 3360(E) 05.11.2013 363 Sevoflurane Inhalation 1 ml 29.76 2850(E) 20.09.2013 364 Sodium Bicarbonate As per IP 1 ml 1.35 2864(E) 20.09.2013 Injection 365 Sodium Nitroprusside 50 mg/ 5 ml Each pack 138.19 1902(E) 28.06.2013 Injection 366 Sodium Stibogluconate 100 mg / ml 1 ml 3.47 3362(E) 05.11.2013 Injection 367 Sodium Valproate Tablets 200 mg, 1 Tablet 3.26 1571(E) 14.6.2013 368 Sodium Valproate syrup 200 mg/5ml 1 ml 0.62 1572(E) 14.6.2013 369 Sodium Valproate Injection 100 mg/ml 1 ml 5.73 1880(E) 28.06.2013 370 Sodium Valproate Tablets 200 mg 1 Tablet 3.26 1571(E) 14.6.2013 371 Sodium Valproate Tablets 500mg 1 Tablet 7.63 1911(E) 28.06.2013 372 Stavudine Capsules 30 mg 1 Capsule 2.92 2841(E) 20.09.2013 373 Stavudine Capsules 40 mg 1 Capsule 3.32 2842(E) 20.09.2013 374 Stavudine+Lamivudine 30mg+ 150mg 1 Tablet 9.78 1593(E) 14.6.2013 Tablets 375 Streptokinase Injection 750,000 IU Each pack 1156.16 1644(E) 14.6.2013 376 Streptokinase Injection 15,00,000 IU Each pack 2162.59 1645(E) 14.6.2013 377 Succinyl Choline Chloride 50 mg/ml 1ml 6.42 3765(E) 20.12.2013 Injection 378 Sulphacetamide Sodium 10% 1 ml 2.46 3377(E) 05.11.2013 Drops 379 Sulphacetamide Sodium 20% 1 ml 2.48 3378(E) 05.11.2013 Drops 380 Tamoxifen Citrate Tablets 10 mg 1 Tablet 4.62 1896(E) 28.06.2013 381 Tamoxifen Citrate Tablets 20 mg 1 Tablet 2.95 1617(E) 14.6.2013 382 Terbutaline Sulphate 2.5 mg 1 Tablet 1.04 1682(E) 14.6.2013 Tablets 383 Terbutaline Sulphate 0.5 mg/ml Each Pack 9.30 3375(E) 05.11.2013 Injection 384 Testosterone Capsules 40mg (as 1 Capsule 11.65 1659(E) 14.6.2013 undecanoate) 385 Tetanus Toxoid Injection 1 ml 10.94 1673(E) 14.6.2013 431(E) 17.2.201428 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 386 Thiopentone Sodium 0.5 gm/pack Each Pack 44.30 1544(E) 14.6.2013 Injection 387 Thiopentone Sodium 1 gm powder 1 gm 49.84 3354(E) 05.11.2013 Injection 388 Timolol Maleate Drops 0.25% 1 ml 4.74 2252(E) 22.07.2013 389 Timolol Maleate Drops 0.50% 1 ml 12.83 2253(E) 22.07.2013 390 Tramadol Injection 50 mg/ml 1 ml 12.47 2231(E) 22.07.2013 391 Tramadol Capsule 50 mg 1 Capsule 6.51 1872(E) 28.06.2013 392 Trihexyphenidyl 2 mg 1 Tablet 1.45 1619(E) 14.6.2013 Hydrochloride Tablets 393 Tropicamide Eye drops 1% 1 ml 10.21 1650(E) 14.6.2013 394 Urokinase Injection 500,000 IU/ml Each Pack 2648.40 3571(E) 02.12.2013 395 Vancomycin 500 mg Each Pack 351.49 1579(E) 14.6.2013 Hydrochloride Injection 396 Vancomycin 1 g Each Pack 546.95 1580(E) 14.6.2013 Hydrochloride Injection 397 Vecuronium Injection 2 mg/ml Each Pack 79.29 1920(E) 28.06.2013 398 Vinblastine sulphate 10 mg/pack Each Pack 302.91 3340(E) 05.11.2013 Injection 399 Vincristine Injection 1 mg / ml Each pack 53.80 1613(E) 14.6.2013 400 Warfarin sodium Tablets 5 mg 1 Tablet 2.38 1621(E) 14.6.2013 401 Water for Injection 5 ml 1 Ampoule 3.67 2865(E) 20.09.2013 Injection 402 Water for Injection 10 ml 1 Ampoule 5.06 2866(E) 20.09.2013 Injection 403 Zidovudine Tablets 300 mg 1 Tablet 15.92 1913(E) 28.06.2013 404 Zidovudine+Lamivudine 300mg+150mg+200 1 Tablet 20.25 1594(E) 14.6.2013 +Nevirapine Tablets mg Note : (a) The above mentioned ceiling prices are applicable with effect from 1st April, 2014. (b) The manufacturers of above mentioned scheduled formulations having maximum retail price higher than the ceiling price specified in column (5) of the table hereinabove, shall revise the MRP to an amount not exceeding the ceiling price plus local taxes, wherever applicable in accordance with paragraph 13 (1) and 24 of the DPCO, 2013. (c) The manufacturer may add local taxes only if they have paid actually or it is payable to the Government on the retail price mentioned in the column (5) of the above table. (d) The ceiling price for a pack of the schedule formulation shall be arrived at by the manufacturer in accordance with the ceiling price specified in column (5) of the above table as per provisions contained in paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall issue a price list in Form–V as per the paragraph 24 (2) of the DPCO, 2013. (e) All the existing manufacturers of above mentioned scheduled formulations having MRP lower than the ceiling price specified in column (5) in the above table plus local taxes as applicable, if any, shall continue to maintain the existing MRP in accordance with paragraph 13 (2) of the DPCO, 2013. (f) Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in the above table, launches a new drug as per paragraph 2 (u) of DPCO,2013 then such existing manufacturer shall apply for prior price approval of such new drug to the NPPA in Form I as specified under schedule-II of the DPCO, 2013.¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 29 (g) The manufacturers of above said scheduled formulation shall furnish quarterly return to the NPPA, in respect of production / import and sale of scheduled formulation in Form-III of Scheduled-II of the DPCO, 2013. Any manufacturer intending to discontinue above said scheduled formulation shall furnish information to the NPPA, in respect of discontinuation of the production and / or import of schedules formulation in Form-IV of scheduled-II of the DPCO, 2013 at least six months prior to the indented date of discontinuation. (h) The manufacturer not complying with the ceiling price and notes specified hereinabove in this notification, shall be liable to deposit overcharged amount along with the interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with the Essential Commodities Act, 1955. (i) Consequent to the issue of ceiling price of the scheduled formulation as specified in column (2) of the above table in this notification, the price order(s) if any, issued prior to the above said date of notification, stand withdrawn. [PN/146/14/2014/F/F. No. 8(14)/2014/D.P./NPPA-Div.-II] MANISH GOSWAMI, Dy. Director vkns'k ubZ fnYyh] 28 vizSy] 2014 dk-vk- 1157¼v½-—jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] Hkkjr ljdkj ds jlk;u vkSj moZjd ea=kky; }kjk tkjh dk0 vk0 1394¼v½ rkjh[k 30 ebZ] 2013 ds lkFk ifBr vkS"k/k ¼dher fu;a=k.k½ vkns'k] 2013 ds iSjk 4, 10, 11 vkSj 14 }kjk iznRr 'kfDr;ksa dk iz;ksx djrs gq,] rFkk Hkkjr ljdkj ds jlk;u vkSj moZjd ea=kky;] jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] ds vkns'k dk- vk- la[;k fofufnZ"V uhps LraHk ¼6½ vkSj ¼7½ dks vf/kØe.k djrs gq,] uhps dh lkj.kh ds LraHk ¼5½ es fofufnZ"V vf/kdre dher dks mDr lkj.kh ds LraHk ¼3½ vkSj ¼4½ es dh Øe'k% rRLFkkuh izfof"V;ksa esa fofufnZ"V izcyrk vkSj bZdkbZ ¼;wfuV½ lfgr ml lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa fofufnZ"V vuqlwfpr fofufeZr;ksa esa ls izR;sd dh] LFkkuh; dj] ;fn dksbZ gS] dks NksM+dj vf/kdre dher ds #i esa fu;r djrh gSA lkj.kh Ø- vuqlwfpr fofufeZfr dk uke izcyrk bZdkbZ vf/kdre dk- vk- fnukad la- dher la[;k ¼#-½ 1 2 3 4 5 6 7 1 dkckZest+kikbu xksfy;ka 200 fexzk- 1 xksyh 1.37 771(v) 10.04.2012 10.04.2012 796(v) 2 flizks¶yksdlhu gkbMªksDyksjkbM 200 fexzk- 1 fefy 0.16 438(v) 10.06.1997 bUtsD'ku /100 fefy 3 dks&VªkbeksDlkt+ksy 40+200 fexzk- 1 fefy 0.24 2700(v) 28.11.2011 ¼VªkbesFkksfize$ / 5 fefy lYQkfeFkkDlkt+ksy½ lLisU'ku 4 dks&VªkbeksDlkt+ksy 160+800 1 xksyh 1.28 2695(v) 28.11.2011 ¼VªkbesFkksfize$ fexzk- lYQkfeFkkDlkt+ksy½ xksfy;ka 5 MkWdlhlkbdfyu xksfy;ka 100 fexzk- 1 xksyh 0.94 2694(v) 28.11.201130 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] 6 tSUVkekbflu bUtsD'ku 40 fexzk-/ 1 fefy 2.18 2762(v) 27.11.2008 fefy 7 LVªsIVksekbflu lYQsV bUtsD'ku 0.75 xzke izfr iSd 7.91 609(v) 27.05.2003 8 xzslks¶;wysfou xksfy;ka 250 fexzk- 1 xksyh 1.45 2326(v) 01.10.2008 9 jsusfVfMu bUtsD'ku 25 fexzk- / 1 fefy 1.43 1508(v) 01.07.2011 fefy 10 MsDlkfeFkkt+ksu xksfy;ka 0.5 fexzk- 1 xksyh 0.19 527(v) 14.03.2011 11 MsDlkfeFkkt+ksu bUtsD'ku 4 fexzk-/ fefy 1 fefy 2.51 1506(v) 01.07.2011 12 lsyC;wVkeksy lYQsV xksfy;ka 2 fexzk- 1 xksyh 0.14 2759(v) 27.11.2008 uksV % ¼d½ tSlk fd mi;qZDr vf/kdre dhersa 1 vizSy] 2014 ls izHkkoh gSA ¼[k½ mi;qZDr lkj.kh ds LraHk ¼5½ es vf/kdre [kqnjk dher gksus ds Åij mYysf[kr vuqlwfpr fofufeZfr;ksa ds fuekZrkvksa dks Mhihlhvks] 2013 ds iSjkxzkQ 13 ¼1½ vkSj iSjk 24 ds rgr vf/kdre dher ls vf/kd LFkkuh; dj] tgka dgh Hkh ykxw gks] ds vuqlkj vukf/kd vf/kd [kqnjk dher dks la'kksf/kr djsxkA ¼x½ vxj fuekZrkvksa us mi;qZDr lkj.kh ds LraHk (5) esa of.kZr vf/kdre dher ij ljdkj dks okLro esa Hkqxrku fd;k gS ;k ;g ns; gS rks os LFkkuh; djksa dks tksM+ ldrs gSA ¼?k½ vkS"k/k ¼ewY; fu;a=k.k½ vkns'k] 2013 ds iSjkxzkQ 11 esa fn, x, izko/kkuksa ds rgr fuekZrkvksa dks mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V vf/kdre dher ds vk/kkj ij vuqlwfpr fofufeZfr;ksa ds iSdksa ds fy, vf/kdre dher fu/kkZfjr djsaA fuekZrk vkS"k/k ¼ewY; fu;a=k.k½ vkns'k] 2013 ds iSjkxzkQ 24¼2½ ds rgr QkWeZ V esa ,d ewY; lwph tkjh djsaA ¼M-½ lHkh ekStwnk fuekZrkvksa dks mi;qZDr dfFkr vuqlwfpr fofufeZfr;ksa ds vf/kdre [kqnjk dher mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V vf/kdre dher LFkkuh; dj lfgr ls de gS rks] tgka dgh Hkh ykxw gks] vkS"k/k ¼ewY; fu;a=k.k½ vkns'k] 2013 ds iSjkxzkQ 13(2) ds vuqlkj mldks ekStwnk vf/kdre [kqnjk dher dks cuk, j[kuk gksxkA ¼p½ mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V vf/kdre dher ds fy, fofufnZ"V vuqlwfpr fofufeZfr;ksa ds fofufnZ"V fofHkUu rjhds vkSj izcyrk ls fHkUu vxj ekStwnk fuekZrkvksa }kjk ,d ubZ vkS"kf/k dks ykap djrk gS rks mls igys vkS"k/k ¼ewY; fu;a=k.k½ vkns'k] 2013 ds iSjkxzkQ 2¼u½ ds vuqlkj vkS"k/k ¼ewY; fu;a=k.k½ vkns'k] 2013 ds rgr lwph II esa fofufnZ"V QkeZ I ds ek/;e ls ,uihih, esa ewY; fu/kkZj.k gsrq vkosnu djuk gksxkA ¼N½ mi;qZDr vuqlwfpr fofufeZfr;ksa dh mRiknu@vk;kr vkSj fcØh ds lEcU/k esa fuekZrkvksa dks vkS"k/k ¼ewY; fu;a=k.k½ vkns'k] 2013 ds lwph II ds QkWeZ III esa Hkjdj ,uihih, dks gj frekgh dh fjiksVZ izLrqr djsxkA mi;qZDr vuqlwfpr fofufeZfr;ksa ds fuekZ.k dks dksbZ fuekZrk mRiknu cUn djus dk bPNqd gks rks bldh lwpuk ,uihih, dks voxr djk;sxkA blds lEcU/k esa vxj vuqlwfpr fofufeZfr;ksa ds mRiknu vkSj vk;kr dks cUn djus dk bPNqd gS rks cUn djus dh frfFk ls N% eghus igys lwph II ds QkWeZ IV esa Hkjdj ,uihih, dks izLrqr djsxkA ¼t½ fofuekZrk ;k foi.ku dEiuh] mijksDr dfFkr lkj.kh esa n'kkZ;s vf/kdre ewY; vkSj 'krks± dk ikyu ugha djrh gSa rks os vko';d oLrq,¡ vf/kfu;e] 1955 ds lkFk ifBr Mhihlhvks] 2013 ds izko/kkuksa ds v/khu C;kt lfgr vf/kizHkkfjr jkf'k dks tek djus ds fy, nk;h gksaxsA¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 31 ¼>½ bl vkns'k esa mijksDr lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa fofufnZ"V vuqlwfpr fofufeZr;ksa ds iSdksa dh vf/kdre dher fu;r gksus ds ifj.kke Lo#i] vkns'k tks fd bl vkns'k ls iwoZ tkjh gq, gS] Lor% gh fujLr gks tk;saxsaA [dka- la-@146@14@2014@fo@Qk- la- 8¼14½@2014@Mhih@,uihih,-&fMoh— II] euh"k xksLokeh] mi&funs'kd ORDER New Delhi, the 28th April, 2014 S.O. 1157(E).—In exercise of the powers, conferred by paragraph 4, 10, 11 and 14 of the Drugs (Prices Control) Order, 2013, read with S.O. No. 1394(E) dated the 30th May, 2013 issued by the Government of India in the Ministry of Chemicals and Fertilizers, and in supersession of the Order of the Government of India in the Ministry of Chemicals and Fertilizers (National Pharmaceutical Pricing Authority) S.O. Number given in specified column no. 6 & 7 mentioned in the below, hereby fixes the prices as specified in column (5) of the table herein below as ceiling prices exclusive of local tax applicable, if any in respect of the Scheduled formulations specified in the corresponding entry in column (2) of the said table with the strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof: TABLE Sr. Name of the Schedule Strengths Unit Ceiling S.O. No. Date No. Formulation Price (Rs.) 1 2 3 4 5 6 7 1 Carbamazepine Tablets 200mg 1 Tablet 1.37 771(E) 10.04.2012 796(E) 10.04.2012 2 Ciprofloxacin Hydrochloride 200 mg /100 1 ml 0.16 438(E) 10.06.1997 Injection ml 3 Co-Trimoxazole 40 + 200 mg / 1 ml 0.24 2700(E) 28.11.2011 (Trimethoprim + 5 ml Sulphamethoxazole) Suspension 4 Co-Trimoxazole 160+800 mg 1 Tablet 1.28 2695(E) 28.11.2011 (Trimethoprim + Sulphamethoxazole) Tablets 5 Doxycycline Tablets 100 mg 1 Tablet 0.94 2694(E) 28.11.2011 6 Gentamicin Injection 40 mg/ml 1ml 2.18 2762(E) 27.11.2008 7 Streptomycin Sulphate 0.75 gm Each 7.91 609(E) 27.05.2003 Injection Pack 8 Griseofulvin Tablets 250 mg 1 Tablet 1.45 2326(E) 01.10.2008 9 Ranitidine Injection 25 mg / ml 1 ml 1.43 1508(E) 01.07.2011 10 Dexamethasone Tablets 0.5mg 1 Tablet 0.19 527(E) 14.03.2011 11 Dexamethasone Injection 4mg/ml 1 ml 2.51 1506(E) 01.07.2011 12 Salbutamol Sulphate Tablet 2 mg 1 Tablet 0.14 2759(E) 27.11.200832 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] Note : (a) The above mentioned ceiling price will be effective from 1st April, 2014. (b) The manufacturers of above mentioned scheduled formulations having maximum retail price higher than the ceiling price specified in column (5) of the table hereinabove, shall revise the MRP to an amount not exceeding the ceiling price plus local taxes, wherever applicable in accordance with paragraph 13 (1) and 24 of the DPCO,2013. (c) The manufacturer may add local taxes only if they have paid actually or it is payable to the Government on the retail price mentioned in the column (5) of the above table. (d) The ceiling price for a pack of the schedule formulation shall be arrived at by the manufacturer in accordance with the ceiling price specified in column (5) of the above table as per provisions contained in paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall issue a price list in Form–V as per the paragraph 24 (2) of the DPCO, 2013. (e) All the existing manufacturers of above mentioned scheduled formulations having MRP lower than the ceiling price specified in column (5) in the above table plus local taxes as applicable, if any, shall continue to maintain the existing MRP in accordance with paragraph 13 (2) of the DPCO, 2013. (f) Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in the above table, launches a new drug as per paragraph 2 (u) of DPCO,2013 then such existing manufacturer shall apply for prior price approval of such new drug to the NPPA in Form I as specified under schedule-II of the DPCO, 2013. (g) The manufacturers of above said scheduled formulation shall furnish quarterly return to the NPPA, in respect of production / import and sale of scheduled formulation in Form-III of scheduled-II of the DPCO, 2013. Any manufacturer intending to discontinue above said scheduled formulation shall furnish information to the NPPA, in respect of discontinuation of the production and / or import of schedules formulation in Form-IV of scheduled-II of the DPCO, 2013 at least six months prior to the indented date of discontinuation. (h) The manufacturer not complying with the ceiling price and notes specified hereinabove in this notification, shall be liable to deposit overcharged amount along with the interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with the Essential Commodities Act, 1955. (i) Consequent to the issue of ceiling price of the scheduled formulation as specified in column (2) of the above table in this notification, the price order(s) if any, issued prior to the above said date of notification, stand withdrawn. [PN/146/14/2014/F/F. No. 8(14)/2014/D.P./NPPA-Div.-II] MANISH GOSWAMI, Dy. Director vkns'k ubZ fnYyh] rkjh[k 28 vizSy] 2014 dk-vk- 1158¼v½-—jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k] Hkkjr ljdkj ds jlk;u vkSj moZjd ea=kky; }kjk tkjh dk0 vk0 1394¼v½ rkjh[k 30 ebZ] 2013 ds lkFk ifBr vkS"k/k ¼dher fu;a=k.k½ vkns'k] 2013 ds iSjk 5, 11 vkSj 15 }kjk iznRr 'kfDr;ksa dk iz;ksx djrs gq,] rFkk Hkkjr ljdkj ds jlk;u vkSj moZjd ea=kky;] jk"Vªh; vkS"k/k ewY; fu/kkZj.k izkf/kdj.k ¼ftldks laf{kIr :i esa ,uihih, dgk tkrk gS½] uhps dh lkj.kh ds LraHk ¼5½ eas fofufnZ"V [kqnjk ewY; dks mDr lkj.kh ds LraHk ¼3½ esa dh Øe'k% rRLFkkuh izfof"V;ksa esa fofufnZ"V izcyk vkSj bZdkbZ ¼;wfuV½ lfgr ml lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa eSllZ vdwEl MªXl ,aM QkekZL;wfVdYl izkbosV fyfeVsM vkSj eSllZ LVªkbM~l vkjdksysc fyfeVsM fufeZr vkSj foi.ku fofufnZ"V fofufeZr;ksa Øe'k% esa ls izR;sd dh] LFkkuh; dj] ;fn dksbZ gS] dks NksM+dj vf/kdre [kqnjk ewY; ds #i esa fu;r djrh gSA¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 33 lkj.kh Ø- vuqlwfpr fofufeZfr dk uke izcyrk bZdkbZ [kqnjk ewY; la- ¼#-½ 1 2 3 4 5 izR;sd vfyfir ck;ys;MZ xksfy;ksa e sa 1. fxykbeijkbM$ fxykbeijkbM-1 fexzk- 1 xksyh 8.46 oksxfycksl$ oksxfycksl-0.2 fexzk- esVQksjfeu ,plh,y esVQksjfeu ,plh,y-500 fexzk- ,l-vkj- xksfy;ka ¼lLVsUM fjfyt+ QkWeZ esa½ jax % jsM vkWDlkbM vkWQ vk;ju 2. fxykbeijkbM$ fxykbeijkbM-2 fexzk- 1 xksyh 10.47 oksxfycksl$ oksxfycksl-0.2 fexzk- esVQksjfeu ,plh,y esVQksjfeu ,plh,y-500 fexzk- ,l-vkj- xksfy;ka ¼lLVsUM fjfyt+ QkWeZ esa½ jax % ;syks vkWDlkbM vkWQ vk;ju uksV % ¼d½ fofuZekrk mi;qZDr nh xbZ fofufnZ"V QkWewZys'ku tks ÞubZ Mªxß Mhihlhvks] 2013 ds iSjkxzkQ 2¼u½ ds rgr mi;qZDr nh xbZ lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; fu/kkZfjr djsaxsA ¼[k½ vxj fuekZrkvksa us mi;qZDr lkj.kh ds LraHk (5) esa of.kZr vf/kdre dher ij ljdkj dks okLro esa Hkqxrku fd;k gS ;k ;g ns; gS rks os LFkkuh; djksa dks tksM+ ldrs gSaA ¼x½ vkS"k/k ¼ewY; fu;a=k.k½ vkns'k] 2013 ds iSjkxzkQ 11 esa fn, x, izko/kkuksa ds rgr fuekZrkvksa dks mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; ds vk/kkj ij vuqlwfpr fofufeZfr;ksa ds iSdksa ds fy, [kqnjk ewY; fu/kkZfjr djsaA fuekZrk vkS"k/k ¼ewY; fu;a=k.k½ vkns'k] 2013 ds iSjkxzkQ 24¼2½ ds rgr QkWeZ V esa ,d ewY; lwph tkjh djsaA ¼?k½ mi;qZDr lkj.kh ds LraHk ¼5½ esa fofufnZ"V [kqnjk ewY; ds fy, fofufnZ"V fofufeZfr;ksa ds fofufnZ"V fofHkUu rjhds vkSj izcyrk ls fHkUu vxj ekStwnk lEcfU/kr fuekZrkvksa }kjk ,d ubZ vkS"kf/k dks ykap djrk gS rks mls igys vkS"k/k ¼ewY; fu;a=k.k½ vkns'k] 2013 ds iSjkxzkQ 2¼u½ ds vuqlkj vkS"k/k ¼ewY; fu;a=k.k½ vkns'k] 2013 ds rgr lwph II esa fofufnZ"V QkeZ I ds ek/;e ls ,uihih, esa ewY; fu/kkZj.k gsrq vkosnu djuk gksxkA ¼M-½ mi;qZDr xSj vf/kdr dher ¼[kqnjk ewY;½ dsoy mi;qZDr fuekZrk@foi.ku ds fy, ykxw gS tSlk fd mUgksaus vkS"k/k ¼ewY; fu;a=k.k½ vkns'k] 2013 ds rgr vuqc) ewY; fu/kkZj.k@la'kks/ku ds fy, QkWeZ I ij tek fd;k x;k Fkk vkSj ljdkj }kjk fu/kkZfjr lHkh ykxw oS/kkfud vko';drkvksa dh iwfrZ ds v/khu izklafxd fof/k;ksa@fu;eksa ds rgr lacaf/kr fofufeZr fuekZrk@foi.ku dEifu;ka tks vuqikyu djrh gSA ¼p½ mi;qZDr fofufeZfr;ksa dh mRiknu@vk;kr vkSj fcØh ds lEcU/k esa lEcfU/kr fuekZrkvksa dks vkS"k/k ¼ewY; fu;a=k.k½ vkns'k] 2013 ds lwph II ds QkWeZ III esa Hkjdj ,uihih, dks gj frekgh dh fjiksVZ izLrqr djsxkA mi;qZDr fofufeZfr;ksa ds fuekZ.k dks dksbZ fuekZrk mRiknu cUn djus dk bPNqd gks rks bldh lwpuk ,uihih, dks voxr djk;sxkA blds lEcU/k esa vxj fofufeZfr;ksa ds mRiknu vkSj vk;kr dks cUn djus34 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(ii)] dk bPNqd gS rks cUn djus dh frfFk ls N% eghus igys lwph II ds QkWeZ IV esa Hkjdj ,uihih, dks izLrqr djsxkA ¼N½ fofuekZrk ;k foi.ku dEiuh] mijksDr fofufeZfr;ksa vkSj fofufnZ"V 'krks± dk ikyu ugha djrh gSa rks os vko';d oLrq,¡ vf/kfu;e] 1955 ds lkFk ifBr Mhihlhvks] 2013 ds izko/kkuksa ds v/khu C;kt lfgr vf/kizHkkfjr jkf'k dks tek djus ds fy, nk;h gksaxsA ¼t½ bl vkns'k esa mijksDr lkj.kh ds LraHk ¼2½ esa dh rRLFkkuh izfof"V esa fofufnZ"V fofufeZr;ksa ds iSdksa dh [kqnjk ewY; fu;r gksus ds ifj.kke Lo#i] vkns'k tks fd bl vkns'k ls iwoZ tkjh gq, gS] Lor% gh fujLr gks tk;saxsA [dka-la-@146@14@2014@fo@Qk- la0 8¼14½@2014@Mhih@,uihih,-&fMoh— II] euh"k xksLokeh] mi&funs'kd ORDER New Delhi, the 28th April, 2014 S.O. 1158(E).—In exercise of the powers, conferred by paragraphs 5, 11 and 15 of the Drugs (Prices Control) Order, 2013, read with S.O. No. 1394(E) dated the 30th May, 2013 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority (hereinafter referred as NPPA) hereby fixes the price as specified in column (5) of the table hereto annexed as the retail price, exclusive of local taxes, if any in relation to each of the formulation specified in the corresponding entry in column (2) of the said table with the strength and unit specified respectively in the corresponding entries in columns (3) and (4) thereof; manufactured and marketed by M/s Akums Drugs & Pharmaceuticals Pvt. Ltd. and M/ s Strides Arcolab Ltd. respectively. TABLE Sl. Name of the Schedule Formulation Strength Unit Retail Price No. Rs. (1) (2) (3) (4) (5) Each uncoated bilayered tablet contains 1. Glimepiride + Glimepiride– 1mg 1 Tablet 8.46 Voglibose + Voglibose-0.2mg Metformin HCl SR Tablets Metformin HCl– 500mg (as Sustained Release) Colour : Red Oxide of iron 2. Glimepiride + Glimepiride– 2mg 1 Tablet 10.47 Voglibose + Voglibose-0.2mg Metformin HCl SR Tablets Metformin HCl– 500mg (as Sustained Release) Colour : Yellow Oxide of iron Note : (a) The manufacturer of above mentioned formulation i.e. “new drug” under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (5) of the table hereinabove. (b) The manufacturer may add local taxes only if they have paid actually or it is payable to the Government on the retail price mentioned in the column (5) of the above table. (c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (5) of the above table as per provisions contained¹Hkkx IIµ[k.M 3(ii)º Hkkjr dk jkti=k % vlk/kj.k 35 in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V as per the paragraph 24 (2) of the DPCO, 2013. (d) Where concerned manufacturer of aforesaid formulation with dosage or strength or both as specified in the above table, launches a new drug as per paragraph 2 (u) of DPCO,2013 then he shall apply for prior price approval of such new drug to the NPPA in Form I as specified under schedule-II of the DPCO, 2013. (e) The above mentioned retail price is applicable only to the individual manufacturers/marketer as mentioned above i.e. who has applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfillment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, by the concerned manufacturers/marketing companies. (f) The concerned manufacturer of above said formulation shall furnish a quarterly return to the NPPA, in respect of its production / import and sale in Form-III of schedule-II of the DPCO, 2013. Manufacturer, in case intending to discontinue above said formulation then he shall furnish information to the NPPA, in respect of discontinuation of the production and / or import of above said formulation in Form-IV of schedule-II of the DPCO, 2013 at least six months prior to the indented date of discontinuation. (g) In case the retail price of aforesaid formulation is not complied as per instant price notification and notes specified hereinabove in this notification, then the concerned manufacturer/marketing company shall be liable to deposit overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955. (h) Consequent to the issue of retail price of the aforesaid formulation as specified in column (2) of the above mentioned table in this notification, the price order(s) if any, issued for concerned manufacturer / marketer prior to the above said date of notification, stand withdrawn. [PN/146/14/2014/F/F. No. 8(14)/2014/D.P./NPPA-Div.-II] MANISH GOSWAMI, Dy. Director Printed by the Manager, Government of India Press, Ring Road, Mayapuri, New Delhi-110064 and Published by the Controller of Publications, Delhi-110054.

Continue your research

Related Documents from Ministry of Chemicals and Fertilizers